<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">92707</article-id><article-id pub-id-type="doi">10.7554/eLife.92707</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.92707.2</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group></article-categories><title-group><article-title>A 2-hydroxybutyrate-mediated feedback loop regulates muscular fatigue</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wadsworth</surname><given-names>Brennan J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9183-227X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Leiwe</surname><given-names>Marina</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0006-7936-6356</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Minogue</surname><given-names>Eleanor A</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Cunha</surname><given-names>Pedro P</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3814-6289</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Engman</surname><given-names>Viktor</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Brombach</surname><given-names>Carolin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Asvestis</surname><given-names>Christos</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0003-5565-030X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Sah-Teli</surname><given-names>Shiv K</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Marklund</surname><given-names>Emilia</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Koivunen</surname><given-names>Peppi</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2827-8229</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Ruas</surname><given-names>Jorge L</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1110-2606</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Rundqvist</surname><given-names>Helene</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5617-9076</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Lanner</surname><given-names>Johanna T</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Johnson</surname><given-names>Randall S</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4084-6639</contrib-id><email>randall.johnson@ki.se</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/056d84691</institution-id><institution>Department of Cell and Molecular Biology, Karolinska Institute</institution></institution-wrap><addr-line><named-content content-type="city">Stockholm</named-content></addr-line><country>Sweden</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/013meh722</institution-id><institution>Department of Physiology, Development and Neuroscience, University of Cambridge</institution></institution-wrap><addr-line><named-content content-type="city">Cambridge</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/056d84691</institution-id><institution>Department of Physiology and Pharmacology, Karolinska Institute</institution></institution-wrap><addr-line><named-content content-type="city">Stockholm</named-content></addr-line><country>Sweden</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03yj89h83</institution-id><institution>Faculty of Medical Biochemistry and Molecular Biology, University of Oulu</institution></institution-wrap><addr-line><named-content content-type="city">Oulu</named-content></addr-line><country>Finland</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/013meh722</institution-id><institution>Department of Biochemistry, University of Cambridge</institution></institution-wrap><addr-line><named-content content-type="city">Cambridge</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/056d84691</institution-id><institution>Department of Laboratory Medicine, Karolinska Institutet</institution></institution-wrap><addr-line><named-content content-type="city">Stockholm</named-content></addr-line><country>Sweden</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Parker</surname><given-names>Benjamin L</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01ej9dk98</institution-id><institution>University of Melbourne</institution></institution-wrap><country>Australia</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Cooper</surname><given-names>Jonathan A</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/007ps6h72</institution-id><institution>Fred Hutchinson Cancer Research Center</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>03</day><month>09</month><year>2024</year></pub-date><volume>12</volume><elocation-id>RP92707</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2023-10-16"><day>16</day><month>10</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2023-10-19"><day>19</day><month>10</month><year>2023</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.10.16.562554"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2023-11-24"><day>24</day><month>11</month><year>2023</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.92707.1"/></event></pub-history><permissions><copyright-statement>© 2023, Wadsworth et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Wadsworth et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-92707-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-92707-figures-v2.pdf"/><abstract><p>Several metabolites have been shown to have independent and at times unexpected biological effects outside of their metabolic pathways. These include succinate, lactate, fumarate, and 2-hydroxyglutarate. 2-Hydroxybutyrate (2HB) is a byproduct of endogenous cysteine synthesis, produced during periods of cellular stress. 2HB rises acutely after exercise; it also rises during infection and is also chronically increased in a number of metabolic disorders. We show here that 2HB inhibits branched-chain aminotransferase enzymes, which in turn triggers a SIRT4-dependent shift in the compartmental abundance of protein ADP-ribosylation. The 2HB-induced decrease in nuclear protein ADP-ribosylation leads to a C/EBPβ-mediated transcriptional response in the branched-chain amino acid degradation pathway. This response to 2HB exposure leads to an improved oxidative capacity in vitro. We found that repeated injection with 2HB can replicate the improvement to oxidative capacity that occurs following exercise training. Together, we show that 2-HB regulates fundamental aspects of skeletal muscle metabolism.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>Exercise</kwd><kwd>muscle fiber</kwd><kwd>metabolite</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004359</institution-id><institution>Vetenskapsrådet</institution></institution-wrap></funding-source><award-id>2022-00755</award-id><principal-award-recipient><name><surname>Johnson</surname><given-names>Randall S</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100006313</institution-id><institution>Barncancerfonden</institution></institution-wrap></funding-source><award-id>PR2023-0072</award-id><principal-award-recipient><name><surname>Johnson</surname><given-names>Randall S</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id award-id-type="doi">10.35802/214283</award-id><principal-award-recipient><name><surname>Johnson</surname><given-names>Randall S</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000024</institution-id><institution>Canadian Institutes of Health Research</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Wadsworth</surname><given-names>Brennan J</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002794</institution-id><institution>Cancerfonden</institution></institution-wrap></funding-source><award-id>180676</award-id><principal-award-recipient><name><surname>Johnson</surname><given-names>Randall S</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004063</institution-id><institution>Knut och Alice Wallenbergs Stiftelse</institution></institution-wrap></funding-source><award-id>2023.0350</award-id><principal-award-recipient><name><surname>Johnson</surname><given-names>Randall S</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001871</institution-id><institution>Fundação para a Ciência e a Tecnologia</institution></institution-wrap></funding-source><award-id>SFRH/BD/115612/2016</award-id><principal-award-recipient><name><surname>Cunha</surname><given-names>Pedro P</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. For the purpose of Open Access, the authors have applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The metabolite 2-hydroxybutyrate is an important aspect of exhaustion which leads to increased capacity in the branched chain amino acid degradation pathway.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Physical exertion is a metabolic challenge that requires physiological responses throughout the body, including a dramatic change to metabolic flux patterns (<xref ref-type="bibr" rid="bib12">Hawley et al., 2014</xref>). During exercise, metabolic end products accumulate and are released into the circulation; prototypical examples of such molecules include hypoxanthine and lactate. Metabolic intermediates of pathways with increased flux during exercise may also exhibit increased levels in the circulation post-exercise, particularly as an indication of pathway saturation (<xref ref-type="bibr" rid="bib34">Sato et al., 2022</xref>). Accumulation of individual exercise-induced metabolites may lead to a diverse range of cellular responses in different tissues, with acute and lasting effects on physiology. Such mechanisms have been defined for succinate (<xref ref-type="bibr" rid="bib31">Reddy et al., 2020</xref>), lactate (<xref ref-type="bibr" rid="bib3">Brooks et al., 2023</xref>), hypoxanthine (<xref ref-type="bibr" rid="bib47">Yin et al., 2021</xref>), and other exerkines (<xref ref-type="bibr" rid="bib12">Hawley et al., 2014</xref>), demonstrating that the exercise-induced metabolome includes factors with significant physiological effects.</p><p>Exercise-induced lactate and succinate exert effects on physiology despite a relatively rapid return to baseline levels during recovery post-exercise. Conversely, 2-hydroxybutyrate (2HB, also known as α-hydroxybutyrate) is an exercise-induced metabolite with plasma concentrations that continue to increase for at least 3 hr after exertion (<xref ref-type="bibr" rid="bib2">Berton et al., 2017</xref>; <xref ref-type="bibr" rid="bib25">Morville et al., 2020</xref>; <xref ref-type="bibr" rid="bib32">Rundqvist et al., 2020</xref>; <xref ref-type="bibr" rid="bib8">Contrepois et al., 2020</xref>). Production of the majority of 2HB in circulation has been attributed to the liver, although 2HB accumulates in many other tissues post-exercise (<xref ref-type="bibr" rid="bib34">Sato et al., 2022</xref>). 2HB is also present in disease states, as untargeted metabolomics analyses have identified 2HB as a metabolic marker for infection severity (<xref ref-type="bibr" rid="bib4">Bruzzone et al., 2020</xref>), and as an indicator of metabolic disorders (<xref ref-type="bibr" rid="bib41">Thompson Legault et al., 2015</xref>; <xref ref-type="bibr" rid="bib11">Gall et al., 2010</xref>; <xref ref-type="bibr" rid="bib36">Sharma et al., 2021</xref>). Cellular responses to accumulated 2HB have not been characterized to date, although <xref ref-type="bibr" rid="bib34">Sato et al., 2022</xref>, report that exogenous administration of 2HB caused an acute shift in mouse whole body metabolism, including a reduction in the respiratory exchange ratio (RER), and increased blood glucose; indicating that 2HB has the potential to alter metabolism.</p><p>2HB is the product of a lactate dehydrogenase (LDH)-mediated reduction of 2-ketobutyrate (2 KB), which itself is a byproduct of endogenous cysteine synthesis via the transsulfuration pathway. Oxidation of 2 KB is not well characterized beyond isolated enzyme assays; these show it to be a substrate for the branched chain keto acid dehydrogenase complex (BCKDH) (<xref ref-type="bibr" rid="bib30">Pettit et al., 1978</xref>). BCKDH converts 2 KB to propionyl-CoA, which can be re-carboxylated by propionyl-CoA carboxylase (PCC), producing the tri-carboxylic acid (TCA) cycle intermediate succinyl-CoA (<xref ref-type="bibr" rid="bib21">Mann et al., 2021</xref>). Mammalian cells are not capable of reverse transsulfuration, that is production of methionine from cysteine; thus, the metabolic fate of 2 KB is driven by the balance between mitochondrial oxidation or reduction to 2HB. Importantly, the metabolism of exogenous 2HB has not been described. Based upon the current literature, the fate of 2HB depends on the capacity for LDH-dependent oxidation of 2HB, and thus, 2 KB metabolic homeostasis.</p><p>2HB is an alpha-hydroxy carboxylic acid similar to 2-hydroxyglutarate (2HG). The latter is a dicarboxylic acid, and an established physiological competitor of α-ketoglutarate (αKG). Both the <italic>S</italic>- and <italic>R</italic>- enantiomers of 2HG are known to competitively inhibit αKG-dependent enzymatic reactions, including the branched chain amino-transferase (BCAT) enzymes, and the much broader family of αKG-dependent dioxygenases (αKGDD) (<xref ref-type="bibr" rid="bib15">Intlekofer et al., 2015</xref>). αKGDDs include regulators of the cellular responses to hypoxia, the prolyl hydroxylase (PHD) and factor inhibiting HIF (FIH), and epigenetic regulators such as lysine demethylases (KDM), among others. Regulation of these targets by endogenous or exogenous <italic>S</italic>-2HG is sufficient to alter numerous cell fate decisions, for example the differentiation of cytotoxic CD8 T cells (<xref ref-type="bibr" rid="bib42">Tyrakis et al., 2016</xref>; <xref ref-type="bibr" rid="bib10">Foskolou et al., 2020</xref>). <italic>R</italic>-2HG inhibition of BCAT is reported to reduce metabolism of branched chain amino acids (BCAA), leading to reduced levels of glutamate and glutathione (<xref ref-type="bibr" rid="bib22">McBrayer et al., 2018</xref>). As an alpha-hydroxy acid, we hypothesised that 2HB may be a novel competitive inhibitor of αKGDDs or BCATs.</p><p>In this work, we investigate the physiological and molecular role of 2HB. We find that cells treated with 2HB demonstrate a metabolic response that leads to transcriptional regulation of BCAA degradation enzymes via a BCAT2 and SIRT4-dependent shift in compartmental protein ADP-ribosylation (ADPr). The reduced ADPr in the nuclear compartment following 2HB treatment promotes binding of the transcription factor CCAAT enhancer binding protein beta (C/EBPβ) to the promoters of BCAA degradation genes. We find that repeated administration of 2HB to mice increases oxidative capacity in exercise tests that replicates the effect of exercise training. Finally, we find repeated 2HB treatment gives rise to an improved resistance to fatigue in oxidative skeletal muscle, consistent with the improvement to oxidative metabolism. Overall, we find that 2HB induces a range of cellular responses that are consistent with it being a feedback signal from exertion, one that leads to increased capacity in the BCAA degradation pathway and improved exercise performance.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Daily 2HB treatment accelerates the metabolic response to exercise in mice</title><p>As described above, physical exertion induces a persistent increase to circulating 2HB. To investigate the role of 2HB in whole animal metabolism, we first subjected mice to daily incremental exhaustive exercise tests for five consecutive days. Immediately following each test, mice were injected with 1 mmol/kg of Na2HB, or an equivalent dose of NaCl as a control (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Mouse basal VO<sub>2</sub>, maximum ΔVO<sub>2</sub> (change in VO<sub>2</sub> relative to basal VO<sub>2</sub>), RER, and ΔVO<sub>2</sub> throughout exercise were similar across treatment groups on the first day, prior to group randomization (<xref ref-type="fig" rid="fig1">Figure 1B–D</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). Median mouse ΔVO<sub>2</sub>max was 507 mL/kg/hr on the first day (<xref ref-type="fig" rid="fig1">Figure 1C</xref>) and mice tended to reach exhaustion during the 21 m/min phase (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). Beyond 18 m/min, mice either further increased their VO<sub>2</sub> or reached exhaustion. This is demonstrated by the lack of correlation between ΔVO<sub>2</sub> during 18 m/min and time-to-exhaustion, but a significant correlation between either ΔVO<sub>2</sub> during 21 m/min or maximum ΔVO<sub>2</sub> and time-to-exhaustion (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). These data demonstrate that increased oxidative capacity predicts improved performance in incremental exercise tests.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Daily 2-hydroxybutyrate treatment recapitulates the benefits of exercise training on oxidative capacity.</title><p>(<bold>A</bold>) Mice were subjected to five days of daily incremental exercise tests to exhaustion followed immediately by injection with 1 mmol/kg of NaCl or Na2HB, N=8. (<bold>B</bold>) Change in VO<sub>2</sub> relative to baseline (ΔVO<sub>2</sub>) versus treadmill speed. (<bold>C</bold>) Maximum ΔVO<sub>2</sub> compared with Day 1. Dunnett’s multiple comparisons test, * p&lt;0.05, ** p&lt;0.01. (<bold>D</bold>) Respiratory exchange ratio (RER) versus treadmill speed. (<bold>E</bold>) Time-to-exhaustion. Mice were subject to a single incremental exercise test (<bold>F</bold>) 2 hr (N=8) or (<bold>G</bold>) 24 hr (N=11) after a single dose, or (<bold>H</bold>) after four daily doses (N=13) of NaCl or Na2HB. For B,D, and F-H, solid lines indicate median values and dashed lines show each replicate. Median plots clipped at 21 m/min due to mouse dropout, although mice may continue up to 30 m/min. Speed vs ΔVO<sub>2</sub> plot shows two-way ANOVA main effect * p&lt;0.05, ΔVO<sub>2</sub> max comparison shows student’s t-test * p&lt;0.05. Time-to-exhaustion plots show Log-Rank test, * p&lt;0.05.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Raw data for <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-92707-fig1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92707-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Supplemental data regarding exercise experiments.</title><p>(<bold>A</bold>) Basal VO<sub>2</sub> for mice in <xref ref-type="fig" rid="fig1">Figure 1A–E</xref> subject to daily incremental exercise tests followed by injection with either 1 mmol/kg of NaCl or Na2HB. Basal VO<sub>2</sub> is measured on each experiment day during a 5-min rest period before treadmill begins moving. N=8. (<bold>B</bold>) ΔVO<sub>2</sub> during indicated speed phase or maximum ΔVO<sub>2</sub> plotted against time-to-exhaustion for mice from <xref ref-type="fig" rid="fig1">Figure 1A–E</xref> on day 5. Pearson correlation coefficients and p values displayed in figure. Data support that mice increase their VO<sub>2</sub> to match the work rate after the initial boost to VO<sub>2</sub> above baseline. (<bold>C</bold>) Mice (N=3) injected with 1 mmol/kg of NaCl or Na2HB immediately prior to sitting in metabolic chamber at rest show no effect of 2HB on VO<sub>2</sub> in first 60 min. (<bold>D</bold>) RER for mice in C. For C,D, solid line displays median, each replicate displayed in dashed lines. (<bold>E</bold>) Basal VO<sub>2</sub> for mice in <xref ref-type="fig" rid="fig1">Figure 1F–H</xref> treated with 1 mmol/kg of NaCl or Na2HB 2 hr, 24 hr, or for 4 days (label 1 WK) prior to exercise test. (<bold>F</bold>) RER for mice in E, mean ± SEM. For E and F, N=8–13. (<bold>G</bold>) Pearson correlation as in B for mice from <xref ref-type="fig" rid="fig1">Figure 1H</xref>. N=13.</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Raw data for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-92707-fig1-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92707-fig1-figsupp1-v2.tif"/></fig></fig-group><p>Mouse ΔVO<sub>2</sub>max tended to increase with subsequent exercise tests and had significantly improved to a median of 877 mL/kg/hr in the control group by day 5 (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Accordingly, progressively more mice reached the 24 m/min phase before exhaustion (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). Mice treated with 2HB showed improvement to ΔVO<sub>2</sub>max in subsequent exercise tests as early as day 3, and increased ΔVO<sub>2</sub>max up to 930 mL/kg/hr on day 5 (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). These data demonstrate a benefit to exercise performance from a brief one-week protocol of exercise training in mice and suggest that combination with exogenous 2HB may accelerate this effect.</p></sec><sec id="s2-2"><title>Daily 2HB treatment recapitulates the benefits of exercise training on oxidative capacity</title><p>We next investigated the effects of exogenous 2HB alone. Firstly, we assessed the effects of acute administration of 1 mmol/kg of Na2HB. For mice at rest, we observed no effect of exogenous 2HB on oxygen consumption or RER compared with NaCl control over the first 60 min, consistent with previous reports for this dose (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C and D</xref>; <xref ref-type="bibr" rid="bib34">Sato et al., 2022</xref>). We next administered 2HB 2 hr prior to an exhaustive exercise test. Both 2HB-treated and control mice reached a ΔVO<sub>2</sub>max of approximately 500 mL/kg/hr, with no difference in RER, time-to-exhaustion, resting VO<sub>2</sub>, or ΔVO<sub>2</sub> during the exercise tests (<xref ref-type="fig" rid="fig1">Figure 1F</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E and F</xref>). These data indicate that exogenous 2HB at a dose of 1 mmol/kg does not acutely alter resting metabolism or oxygen consumption during exercise.</p><p>Next, we investigated whether treatment with 2HB would alter exercise performance on subsequent days. First, a cohort of mice was treated with 2HB 24 hr prior to an exhaustive exercise test. In these mice there was again no difference between groups in terms of resting VO<sub>2</sub>, ΔVO<sub>2</sub> or RER during the exercise test, time-to-exhaustion, or ΔVO<sub>2</sub>max (<xref ref-type="fig" rid="fig1">Figure 1G</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E and F</xref>). When mice were treated with 2HB each day for four days with the exhaustive exercise test on the fifth day, 2HB-treated mice exhibited an increased ΔVO2 during the exercise test, with differences more apparent at greater treadmill speeds (<xref ref-type="fig" rid="fig1">Figure 1H</xref>). Oxygen consumption at higher treadmill speeds correlated with greater time-to-exhaustion, indicating effective oxidative capacity as opposed to metabolic inefficiency (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1G</xref>). Mice treated with 2HB exhibited a greater ΔVO<sub>2</sub>max and greater time-to-exhaustion, but had similar basal VO<sub>2</sub> and RER levels throughout exercise, relative to exercising NaCl-treated controls (<xref ref-type="fig" rid="fig1">Figure 1H</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E and F</xref>). Control mice exhibited a median ΔVO<sub>2</sub>max of 572 ml/kg/hr. However, 2HB-treated mice exhibited a median ΔVO<sub>2</sub>max of 828 mL/kg/hr, similar to exercise-trained mice (<xref ref-type="fig" rid="fig1">Figure 1C and H</xref>). These data indicate that repeated 2HB treatment replicates the improvement to mouse oxidative capacity and exercise performance produced from daily exercise training.</p></sec><sec id="s2-3"><title>2HB levels are correlated with metabolic indicators of BCAA degradation in murine datasets</title><p>To determine which metabolic pathways 2HB may affect, we were next interested in determining which metabolites are most correlated with 2HB post-exercise. We analyzed two published datasets reporting untargeted metabolomics in mice subjected to a treadmill-based exercise protocol, or sham control (<xref ref-type="bibr" rid="bib34">Sato et al., 2022</xref>; <xref ref-type="bibr" rid="bib32">Rundqvist et al., 2020</xref>). Both studies observe a strong increase to 2HB in the circulation and in all assessed organs post-exercise (<xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). A correlation analysis demonstrates a reliable positive correlation between circulating 2HB and markers of BCAA metabolism (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Overrepresentation analysis of BCAA-related metabolites positively correlated with 2HB post-exercise yielded p values of 3.8x10<sup>–5</sup> and 1.6x10<sup>–2</sup> for the two studies. These data suggest that accumulation of 2HB is correlated to the metabolic flux through the BCAA degradation pathway.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Exercise datasets suggest relation between 2-hydroxybutyrate and BCAA metabolism.</title><p>(<bold>A</bold>) Volcano plots display partial correlation coefficients for metabolites present in the blood that correlate with 2HB levels in mice that have undergone exercise. BCAA degradation metabolites indicated. Data in A are from <xref ref-type="bibr" rid="bib34">Sato et al., 2022</xref> (<italic>left</italic>) and <xref ref-type="bibr" rid="bib32">Rundqvist et al., 2020</xref> (<italic>right</italic>). (<bold>B</bold>) Levels of amino acid, keto-acid, and hydroxy acid versions of the BCAA and 2HB are displayed for human subjects comparing pre-exercise measures with those immediately post exercise and 1-hr post-exercise. Data from <xref ref-type="bibr" rid="bib32">Rundqvist et al., 2020</xref>, N=8, median ±interquartile range. Dunnett’s multiple comparisons test made against pre-exercise levels, *** p&lt;0.001, ** p&lt;0.01, * p&lt;0.05. (<bold>C</bold>) Mice were treated with 1 mmol/kg of NaCl or Na2HB for four days prior to a single endurance exercise protocol consisting of a gradual warm-up and 30 min of running at 18 m/min. Sham control mice placed on motionless treadmill. (<bold>D</bold>) ΔVO<sub>2</sub> and (<bold>E</bold>) RER plots, Left-to-Right: group medians, vehicle-treated, and 2HB-treated. (<bold>F</bold>) No effect of 2HB on basal VO<sub>2</sub>, Dunnett’s multiple comparisons test. (<bold>G</bold>) 2HB-treated mice show increased average ΔVO<sub>2</sub>. Student’s t-test, * p&lt;0.05. Untargeted metabolomics was conducted on serum, red gastrocnemius, and white gastrocnemius from mice in figures <bold>C-G</bold>. Heat maps of top 50 most differentially abundant metabolites in (<bold>H</bold>) serum, (<bold>I</bold>) white gastrocnemius, and (<bold>J</bold>) red gastrocnemius. Unique mouse ID displayed with group abbreviations: ‘VS’ vehicle-sedentary, ‘HS’ 2HB-sedentary, ‘VR’ vehicle-runner, ‘HR’ 2HB-runner. (<bold>K</bold>) BCAA degradation pathway. (<bold>L</bold>) Heat map displays metabolites in the BCAA degradation pathway. For D-L, N=6. Heat maps display standardized row medians.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Raw data for <xref ref-type="fig" rid="fig2">Figure 2</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-92707-fig2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92707-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Supplemental data regarding 2-hydroxybutyrate and BCAA metabolomics.</title><p>(<bold>A</bold>) Raw 2HB measures from metabolomics datasets for each organ assessed in Sato et al. and Rundqvist et al. studies. Sidak multiple comparison test results displayed. Plots display VO<sub>2</sub>-adjusted standardized values for the amino, oxo-, and hydroxy- versions of the branched chain amino acids, and 2HB for mice corresponding to <xref ref-type="fig" rid="fig2">Figure 2C–L</xref>, for (<bold>B</bold>) red gastrocnemius, (<bold>C</bold>) white gastrocnemius, and (<bold>D</bold>) serum. All data are N=6. Comparisons made between vehicle and 2HB-treated groups of matching exercise condition. Fisher’s LSD test results displayed. * p&lt;0.05, ** p&lt;0.01, *** p&lt;0.001.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Raw data for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-92707-fig2-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92707-fig2-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-4"><title>Human exercise studies demonstrate the persistence of serum 2HB post-exercise</title><p>We further investigated this pattern by assessing the plasma metabolomics of human subjects in a previously published dataset from our group. In this study, blood was sampled prior to exercise, immediately post-exercise, and then 1-hr post-exercise. Few markers of BCAA degradation are available in the human dataset, so we focused on the amino acid, the keto acid, and the hydroxy acid versions of leucine, isoleucine, valine, and 2HB. Transamination of BCAA to the respective keto acid is the first step towards mitochondrial oxidation. In line with this, BCAA levels are reduced immediately post-exercise compared with pre-exercise levels, while keto acids and hydroxy acids are increased (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). The accumulation of 2HB alongside increased BCAA degradation is consistent with a model wherein BCAAs compete with 2 KB for early oxidation steps, for example the BCKDH and PCC-mediated reactions.</p><p>Indicating a return to homeostasis, 1-hr after completion of exercise, BCAAs increase and keto acids decrease towards pre-exercise levels (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). The hydroxy acids are intriguing, as these remain significantly greater than pre-exercise levels even 1-hr after completion of exercise, suggesting slow clearance of all members of this metabolite group, including 2HB. Among the hydroxy acids, 2HB is the standout, with the greatest fold-increase at the 1-hr time point and the greatest absolute abundance in both human and mouse datasets (<xref ref-type="bibr" rid="bib32">Rundqvist et al., 2020</xref>). Collectively, these data describe a positive correlation for the production of 2HB in proportion with production of branched chain keto acids (BCKA) during exercise. The slow clearance of 2HB and the branched chain hydroxy acids (BCHA) represent a possible indication of saturation in the capacity for the oxidation of 2 KB and BCKAs.</p></sec><sec id="s2-5"><title>Repeated 2HB treatment alters BCAA metabolite balance following exercise</title><p>We next investigated whether repeated treatment of 2HB for four days would alter BCAA metabolism during an exercise test on the fifth day. To limit mouse dropout from exhaustion, the exercise protocol increased speed only up to 18 m/min. This speed was held for 30 min for all mice (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). There was no effect of 2HB treatment on basal VO<sub>2</sub>, or on RER throughout the exercise protocol (<xref ref-type="fig" rid="fig2">Figure 2D–F</xref>). 2HB-treated mice tended to spend more time running on the treadmill, indicated by an increased ΔVO<sub>2</sub> during the 18 m/min segment of the exercise protocol (<xref ref-type="fig" rid="fig2">Figure 2D and G</xref>). These data demonstrate again that repeated 2HB treatment increases oxidative capacity during exercise.</p><p>We hypothesized that the change to exercise performance, in both the incremental exercise tests to exhaustion and moderate exercise tests, was in part due to a change in skeletal muscle metabolism during exercise. Untargeted metabolomics of mouse serum, red gastrocnemius, and white gastrocnemius collected immediately post-exercise shows modest clustering of mice based on treatment group in the serum, separating vehicle-treated sedentary controls from other treatment groups (<xref ref-type="fig" rid="fig2">Figure 2H</xref>). Conversely, we observe strong clustering in the red and white gastrocnemius, delineating each experimental group (<xref ref-type="fig" rid="fig2">Figure 2I and J</xref>). These data begin to suggest that skeletal muscle is a site of metabolic regulation by 2HB.</p><p>When we visualize the data trends in the BCAA metabolic pathway within each tissue (<xref ref-type="fig" rid="fig2">Figure 2K and L</xref>), a shift in the BCAA, BCKA, and BCHA appears to be exercise and 2HB dependent; specifically 2HB treatment appears to reduce BCAA levels in red gastrocnemius at rest and during exercise, but increase BCKA and decrease the hydroxy acids during exercise (<xref ref-type="fig" rid="fig2">Figure 2L</xref>). The levels of intermediates within the BCAA degradation pathway increase in each compartment with exercise, with no strong effect of 2HB. These data suggest a shift in red gastrocnemius BCAA homeostasis induced by 2HB treatment.</p><p>To compare the effects of 2HB given the quantifiable difference in exercise performance (<xref ref-type="fig" rid="fig2">Figure 2D–G</xref>), we adjusted metabolite values based on VO<sub>2</sub> measures during the exercise protocol or sham control. This adjustment yields values that indicate whether the levels of a given metabolite were high or low relative to the matching VO<sub>2</sub> measures for each mouse. We observed a number of differences and trends in the red gastrocnemius muscle: reduced levels of BCAA at rest and post-exercise, increased BCKA post-exercise, reduced BCHA post-exercise, and reduced 2HB post-exercise (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). In white gastrocnemius we only observe a reduction to BCAA and the BCHA post-exercise (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>). Each of these effects are weaker in the serum VO<sub>2</sub>-adjusted data (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>). These data demonstrate that 2HB treatment alters muscle BCAA metabolic balance in excess of the changes to mouse VO<sub>2</sub> during exercise.</p></sec><sec id="s2-6"><title>2KB is a fuel for oxidative metabolism</title><p>The metabolomics analysis led us to hypothesize that physiological 2HB accumulation is associated with competition for the BCAA degradation pathway, limiting oxidation of 2 KB. However, despite validation as a substrate for BCKDH in isolated enzyme assays (<xref ref-type="bibr" rid="bib30">Pettit et al., 1978</xref>), 2 KB has not been validated as a potential fuel for mitochondrial oxidative metabolism. Thus, we next aimed to investigate the potential of 2HB and 2 KB as fuel for oxidative metabolism in vitro and dependency of 2 KB oxidation on the BCAA degradation pathway. We subjected cells to Seahorse assays monitoring the oxygen consumption rate (OCR) during a standard ‘mitochondrial stress test’ protocol following acute administration of 500–5000 μM of either Na2HB, Na2KB, or NaCl control (<xref ref-type="fig" rid="fig3">Figure 3A and B</xref>). With C2C12 myoblasts, we found a modest increase to OCR immediately following 2 KB addition, with no response to 2HB (<xref ref-type="fig" rid="fig3">Figure 3A and B</xref>). Presence of 2HB or 2 KB provided a small increase to the maximum OCR. We hypothesized that the standard assay media saturated cells with fuel, leaving little capacity for 2HB or 2 KB as a fuel. We therefore repeated the assays with no pyruvate in the medium. Similarly, an acute uptick in OCR was observed upon addition of 2 KB, but not 2HB (<xref ref-type="fig" rid="fig3">Figure 3A and B</xref>). There was now a dose-dependent increase to maximal OCR in cells treated with 2 KB, up to a similar magnitude when pyruvate was included. Addition of 2HB was not able to recapitulate the maximum OCR observed when pyruvate was present in the media. These trends could be replicated with mouse embryonic fibroblasts (MEF), although with a lower magnitude (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). These data demonstrate that 2 KB is a substantially greater fuel for oxidative metabolism than 2HB.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>2-Ketobutyrate oxidation depends upon an in tact BCAA degradation pathway.</title><p>(<bold>A,B</bold>) Oxygen consumption rate (OCR) during mitochondrial stress test with acute administration of (<bold>A</bold>) Na2KB or (<bold>B</bold>) Na2HB as indicated. N=4 independent assays, mean ± SD. Basal and maximum OCR values displayed with Sidak’s multiple comparisons test displayed, * p&lt;0.05, **** p&lt;0.0001. (<bold>C</bold>) Maximum OCR values from mitochondrial stress tests in C2C12 transfected with siRNA against indicated targets, N=4 independent assays mean ± SD. Sidak’s multiple comparisons test, *** p&lt;0.001. (<bold>D</bold>) Relative reaction rate of LDH assays using indicated substrate. Data are normalized to the maximum reaction rate for a given experiment day for each reaction direction. Data are a summary of five independent experiment days, mean ± SD. (<bold>E</bold>) Summary figure; we propose that accumulation of 2HB, as occurs post-exertion, is an indicator of saturation in the BCAA degradation pathway, leading to reduction of 2 KB instead of mitochondrial oxidation and the potential for metabolic feedback via 2HB. (<bold>F</bold>) Heatmap summarizing RT-qPCR for C2C12 myoblasts treated with 500 μM of Na2HB or NaCl for 8 hr. N=4 independent assays, median row z-score displayed with Sidak’s multiple comparisons test, * p&lt;0.05.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Raw data for <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-92707-fig3-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92707-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Supplemental data regarding the BCAA degradation pathway.</title><p>(<bold>A</bold>) OCR during mitochondrial stress test with acute administration of 500 μM Na2HB or Na2KB as indicated. N=4 independent assays, mean ± SD. (<bold>B</bold>) qPCR validation of reduced target gene expression for siRNA transfected cells. Final siRNA selection was based on knockdown of target gene expression in control and 2HB-treated cells; siBCKDHA #2 and siPCCA #3. (<bold>C</bold>) LDH activity assays using keto- and hydroxy-acid versions of BCAA as substrates. From left to right, metabolites are the leucine, isoleucine, and valine derived metabolites; KIC = ketoisocaproate, 2O3MV = 2-oxo-3-methylvalerate, 2O3MB = 2-oxo-3-methylbutyrate, HIC = hydroxyisocaproate, 2H3MV = 2-hydroxy-3-methylvalerate, and 2H3MB = 2-hydroxy-3-methylbutyrate. Data are normalized to the maximum reaction rate in the given reaction direction for the matched experiment day. Data represent mean ± SD of three independent experiment days.</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Raw data for <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-92707-fig3-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92707-fig3-figsupp1-v2.tif"/></fig></fig-group><p>It is possible that the increase to maximal OCR induced by 2 KB is due to 2 KB promoting glycolysis (<xref ref-type="bibr" rid="bib39">Sullivan et al., 2015</xref>; <xref ref-type="bibr" rid="bib18">Lesner et al., 2020</xref>), instead of 2 KB being used as a fuel. To investigate the importance of the BCAA degradation pathway for 2 KB metabolism, we repeated these experiments in cells transfected with siRNA against <italic>BCKDHA</italic>, <italic>PCCA</italic>, and <italic>HPRT</italic> as an off-target control, or non-targeting siRNA control (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>). Transfection alone had insignificant effects on maximum OCR, as demonstrated by cells treated with NaCl. Addition of 500 μM 2 KB increased maximum OCR as before, however, this was inhibited in cells transfected with siRNA against <italic>PCCA</italic> (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). These data suggest that an intact BCAA degradation pathway is required for 2 KB promotion of maximal OCR in vitro, indicating that 2 KB can be used as a fuel for oxidative metabolism.</p></sec><sec id="s2-7"><title>2HB is slowly metabolized by LDH</title><p>The poor suitability of 2HB as a fuel relative to 2 KB suggests slow conversion to 2 KB. Interconversion between 2HB and 2 KB is proposed to occur via LDH. Thus, we aimed to quantify the relative rate of 2HB oxidation and 2 KB reduction. We conducted activity assays using LDH isolated from bovine skeletal muscle or bovine heart. The former is enriched for LDH isoenzymes with M subunits from <italic>LDHA</italic> expression, while the latter is enriched for LDH isoenzymes with H subunits due to predominant <italic>LDHB</italic> expression. As previously reported, 2 KB was an efficient substrate for both LDH enzymes, with a maximum relative reaction rate greater than pyruvate (<xref ref-type="fig" rid="fig3">Figure 3D</xref>; <xref ref-type="bibr" rid="bib43">von Morze et al., 2016</xref>). However, 2HB exhibited a maximum reaction rate that was only ~30% that of lactate using bovine heart LDH, and ~15% of lactate using bovine skeletal muscle LDH (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). These data support a mechanism for the efficient production of 2HB from 2 KB, leading to long-lasting 2HB accumulation post-exercise.</p><p>Further, we found very low reaction rates for reduction of the BCKA, with a rate between ~2 and 10% the reaction rate of pyruvate. The greatest reaction rate observed was for the keto acid of valine, 2-oxo-3-methylbutyrate, using bovine heart LDH (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>). No signal was detected above background for the oxidation reaction of any BCHA. These data would be consistent with the relatively low abundance of BCHA, and their slow rate of clearance.</p></sec><sec id="s2-8"><title>2HB metabolic feedback occurs via BCAT inhibition</title><p>The slow metabolic processing of 2HB makes it likely to accumulate in cells and trigger a functional response. Based on the effects of 2HB treatment on BCAA, BCKA, and BCHA levels post-exercise (<xref ref-type="fig" rid="fig2">Figure 2</xref>), we hypothesized that 2HB provides metabolic feedback to the BCAA degradation pathway (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). As an initial test, we found that culturing C2C12 myoblasts with 500 μM of 2HB increased gene expression of multiple factors involved in BCAA degradation, including those involved in 2 KB oxidation such as <italic>BCKDHA</italic>, and <italic>PCCA</italic> (<xref ref-type="fig" rid="fig3">Figure 3F</xref>).</p><p>Based on the structural similarities between 2HB and 2HG, we hypothesized that 2HB may act as a competitive inhibitor of BCAT enzymes. To test this possibility, we conducted activity assays of recombinant human BCAT2 (rhBCAT2) using leucine as a constant substrate and αKG as a varied concentration substrate. In these assays, we find a dose dependent reduction to maximal rhBCAT2 activity with increasing concentrations of 2HB in the reaction well (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). We conducted similar assays using rhGOT1, an aspartate-oxaloacetate aminotransferase, but found no effect of 2HB on the reaction rate (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). Given the modification of BCAT activity, it seemed plausible that 2HB may compete with αKG for active sites in αKGDDs. However, in assays of isolated HIFP4H1 and HIFP4H2, no more than 5% inhibition was observed for concentrations of 2HB up to 10 mM, and similarly little inhibition was observed for assays of isolated KDM6A (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref> <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). These data indicate that 2HB inhibits specifically BCAT activity.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>2-Hydroxybutyrate feedback mecanism.</title><p>(<bold>A</bold>) Relative reaction rate for recombinant human BCAT2 activity assays. Leu was kept at a constant concentration of 5 mM, 2HB concentrations are indicated in the legend. Data are normalized to the maximum reaction rate for a given experiment day and data represent three independent experiment days, mean ± SD. (<bold>B</bold>) Indicated metabolites were added to culture media for indicated time prior to cell harvest for NAD +and NADH assays, NAD+/NADH ratio displayed. N=8 independent assays, Dunnett’s multiple comparisons test, **** p&lt;0.0001, * p&lt;0.05. (<bold>C</bold>) C2C12 myoblasts were transfected with vector control or DDK-tagged hBCAT2 before repeating the 60-min time point NAD +and NADH assays. 1 mM Aminooxyacetic acid (AOA) included as positive control. N=12 independent assays, Dunnett’s multiple comparisons test, * p&lt;0.05. (<bold>D</bold>) RT-qPCR gene expression for factors related to 2HB and BCAA metabolism in MEFs and C2C12 transfected with siRNA against SIRT4 or non-targeting control, and treated with 500 μM NaCl or Na2HB for 8 hr. N=4 independent assays, median row z-score displayed. (<bold>E</bold>) Total protein ADP ribosylation western blots from cytoplasmic and nuclear extracts of C2C12 cells transfected with siRNA against SIRT4 or non-targeting control and treated with 500 μM NaCl or Na2HB for 16 hr. Representative blots shown and quantification from three independent experiments. N=3, Sidak multiple comparisons test, * p&lt;0.05. (<bold>F</bold>) Immunoprecipitation was conducted on C2C12 nuclear extracts using either antibody against C/EBPβ or poly/mono-ADP ribose, with resultant membranes probed using the opposite antibody. Total C/EBPβ and histone 3 were detected in input samples. N=3, two-way ANOVA main effect, ** p&lt;0.01, * p&lt;0.05. (<bold>G</bold>) ChIP-qPCR conducted on C2C12 myoblast lysates treated with 500 μM of NaCl or Na2HB for 8 hr. (<bold>I</bold>) Summary figure displaying proposed mechanism.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Raw data for <xref ref-type="fig" rid="fig4">Figure 4</xref> and western blots.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-92707-fig4-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>Labeled western blots.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92707-fig4-data2-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata3"><label>Figure 4—source data 3.</label><caption><title>Unlabeled western blots.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92707-fig4-data3-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92707-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Supplemental data regarding the 2-hydroxybutyrate feedback mechanism.</title><p>(<bold>A</bold>) Relative reaction rate for recombinant human Got1 activity. Amino-oxyacetate (AOA) was used as a positive control for Got1 inhibition. Data represent mean ± SD of three independent experiment days. (<bold>B</bold>) Total protein stains for western blots in <xref ref-type="fig" rid="fig4">Figure 4C</xref>. (<bold>C</bold>) RT-qPCR validation of siRNA against SIRT4. siRNA#3 was selected for experiments in main figures. (<bold>D</bold>) Total protein stains for western blots in <xref ref-type="fig" rid="fig4">Figure 4E</xref>.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Raw data for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-92707-fig4-figsupp1-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4s1sdata2"><label>Figure 4—figure supplement 1—source data 2.</label><caption><title>Labeled western blots.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92707-fig4-figsupp1-data2-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig4s1sdata3"><label>Figure 4—figure supplement 1—source data 3.</label><caption><title>Unlabeled western blots.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92707-fig4-figsupp1-data3-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92707-fig4-figsupp1-v2.tif"/></fig></fig-group><p>Inhibition of BCAT enzymes may induce a range of metabolic disruptions. To broadly investigate cellular response to acute exogenous 2HB, we quantified cellular NAD+/NADH ratio after addition of 500 μM 2HB to culture media. In C2C12 lysates harvested 60 min following addition of 2HB we found an increase to the NAD+/NADH ratio, indicating a drop in the cellular reducing potential (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). If cells were harvested after overnight culture, NAD+/NADH ratio had rebounded. There was no effect of treating cells with 2 KB, indicating that this metabolic response was specific to 2HB. These findings were replicated in MEFs (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). To determine if the NAD+/NADH shift induced by 2HB exposure was dependent upon BCAT expression, we transfected C2C12 cells with a vector driving constitutive expression of DDK-tagged hBCAT2, or empty vector control. The increase to NAD+/NADH could be replicated in vector control cells, but the NAD+/NADH ratio in hBCAT2-transfected cells was insensitive to 2HB addition (<xref ref-type="fig" rid="fig4">Figure 4C</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>). These data describe an acute metabolic shock induced by addition of 2HB to cells, dependent upon BCAT inhibition.</p></sec><sec id="s2-9"><title>2HB treatment stimulates SIRT4 ADP ribosyltransferase activity</title><p>Increases to cellular NAD +are sensed by Sirtuins, a family of deacetylase enzymes that modify cellular metabolism. Sirtuin 4 (SIRT4) is localised to the mitochondria and is previously described to induce increased expression and post-translational activation of the BCAA degradation pathway (<xref ref-type="bibr" rid="bib1">Anderson et al., 2017</xref>; <xref ref-type="bibr" rid="bib48">Zaganjor et al., 2021</xref>). We hypothesized that SIRT4 would be stimulated by the acute shift in NAD +induced by exogenous 2HB, and that SIRT4 may drive the cellular response to 2HB. First, we transfected MEFs and C2C12 myoblasts with siRNA against SIRT4 and checked for transcriptional induction of BCAA degradation pathway genes following overnight culture in media supplemented with 500 μM 2HB or NaCl control (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref> C). We found induction of genes including <italic>BCAT2</italic>, <italic>BCKDHA</italic>, <italic>BCKDHB</italic>, <italic>PCCA</italic>, <italic>SLC7A5</italic>, as well as <italic>LDHB</italic> and <italic>LDHA</italic> in both MEFs and C2C12s treated with 2HB compared with controls. Transfection with siRNA against SIRT4 disrupted the induction of these genes when cells were treated with 2HB (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). These data indicate that expression of SIRT4 is critical for the transcriptional feedback induced by 2HB treatment.</p><p>SIRT4 is perhaps better characterized as an ADP ribosyl transferase than as a deacetylase (<xref ref-type="bibr" rid="bib23">Min et al., 2018</xref>). Addition of ADPr to protein requires consumption of local NAD+. Replacing the consumed NAD +can cause a compartmental shift in the supply of NAD+, and therefore the source of protein ADPr (<xref ref-type="bibr" rid="bib14">Hopp et al., 2021</xref>). Thus, metabolic activity in one compartment may induce transcriptional change via regulating ADPr of transcription factors within the nucleus. To investigate the ability of SIRT4 to regulate compartmental ADPr, we separated cytoplasmic and nuclear extracts of C2C12 myoblasts transfected with siRNA against <italic>SIRT4</italic>, or non-targeting control, treated with 500 μM 2HB or NaCl control for 16 hr. In western blots detecting total poly/mono-ADPr, we see that 2HB treatment increases ADPr in the cytoplasmic compartment, while reducing ADPr in the nuclear extracts, each dependent upon SIRT4 (<xref ref-type="fig" rid="fig4">Figure 4E</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D</xref>). We were next interested in whether 2HB-induced SIRT4 activity might alter the ADPr of a transcription factor relevant to regulation of metabolism. C/EBPβ has been described to regulate adipogenesis (<xref ref-type="bibr" rid="bib33">Ryu et al., 2018</xref>), which is also known to involve SIRT4-dependent regulation of BCAA metabolism (<xref ref-type="bibr" rid="bib48">Zaganjor et al., 2021</xref>; <xref ref-type="bibr" rid="bib33">Ryu et al., 2018</xref>). Importantly, C/EBPβ transcriptional activity was shown to be dependent upon compartmental ADPr, wherein C/EBPβ ADPr reduces its transcriptional activity (<xref ref-type="bibr" rid="bib33">Ryu et al., 2018</xref>). Therefore, we conducted immunoprecipitation experiments pulling down total poly/mono-ADPr protein from C2C12 nuclear extracts and blotting for C/EBPβ, or vice versa. We observed a strong effect of SIRT4 knockdown leading to increased ADPr of C/EBPβ, and a trend towards reduced C/EBPβ ADPr in cells treated with 500 μM 2HB for 8 hr (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). It is possible that a small shift in ADPr may lead to significant changes to C/EBPβ transcriptional activity. We therefore continued by conducting chromatin immunoprecipitation experiments pulling down C/EBPβ and conducted qPCR for different promoter regions in the genes of <italic>BCKDHA</italic> and <italic>PCCA</italic> containing C/EBPβ consensus binding sites. We found that treating cells with 500 μM 2HB for 8 hr stimulated binding of C/EBPβ to both gene promoters (<xref ref-type="fig" rid="fig4">Figure 4G and H</xref>). In summary, we find that treating cells with exogenous 2HB induces a metabolic response via BCAT inhibition, which stimulates SIRT4 to trigger a compartmental change in protein ADPr, leading to C/EBPβ binding to <italic>BCKDHA</italic> and <italic>PCCA</italic> genes (<xref ref-type="fig" rid="fig4">Figure 4I</xref>). These data present a mechanism for feedback on the BCAA degradation pathway induced by 2HB accumulation.</p></sec><sec id="s2-10"><title>2HB promotes oxidative metabolism in vitro via the BCAA degradation pathway</title><p>We hypothesized that overnight culture with 2HB would increase the expression of BCAA degradation pathway genes and thus promote oxidative metabolism. MEFs and C2C12s were treated overnight with 500 μM of Na2HB, or NaCl control prior to running a mitochondrial stress test or glycolysis stress test to quantify OCR and extracellular acidification rate (ECAR) respectively. Overnight treatment with either 2HB increased both the basal and maximal OCR in MEFs and C2C12s (<xref ref-type="fig" rid="fig5">Figure 5A and B</xref>). MEFs exhibited an increased ECAR, indicative of increased glycolytic capacity from treatment with 2HB (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>). Collectively, these data indicate increased metabolic activity, and particularly an increase to oxidative capacity from overnight culture with 2HB.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>2-Hydroxybutyrate promotes oxidative metabolism in vitro<italic>.</italic></title><p>(<bold>A</bold>) C2C12 and (<bold>B</bold>) MEFs cultured overnight in media containing 500 μM of Na2HB, or NaCl as indicated, prior to mitochondrial stress test, mean ± SD. Basal and maximum OCR values displayed with Student’s t-test results; N=6 independent assays ** p&lt;0.01, * p&lt;0.05. OCR during mitochondrial stress tests, basal OCR, and maximum OCR for (<bold>C</bold>) C2C12s and (<bold>D</bold>) MEFs transfected with siRNA against indicated gene targets. N=4 independent assays, mean ± SEM Sidak’s multiple comparisons test, **** p&lt;0.0001, *** p&lt;0.001, * p&lt;0.05.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Raw data for <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-92707-fig5-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92707-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Supplemental data regarding the effects of 2-hydroxybutyrate treatment in vitro.</title><p>(<bold>A</bold>) Extracellular acidification rate for C2C12 and MEFs cultured overnight in media containing 500 μM of either NaCl or Na2HB. N=4 independent assays, mean ± SD. Dunnett’s multiple comparisons test, * p&lt;0.05. (<bold>B</bold>) OCR during mitochondrial stress test and maximum OCR for MEFs and C2C12s treated daily with 500 μM of Na2HB or NaCl supplemented media for 3 days with assays run on day 4. N=4 independent assays, Sidak’s multiple comparisons test, ** p&lt;0.01, * p&lt;0.05. (<bold>C</bold>) Representative western blot and quantification for histones isolated from MEFs treated for 3 days with 500 μM of Na2HB or NaCl, with or without the DOT1L methyltransferase inhibitor EPZ004777. Amounts of protein loaded are indicated above each blot. (<bold>D</bold>) Representative western blots and quantification using histones isolated from C2C12 cells treated for 3 days with 2HB or NaCl control at indicated concentrations. EPZ004777 was used as a positive control DOT1L inhibitor. (<bold>E</bold>) Representative western blot using OXPHOS antibody cocktail from C2C12 (left) and MEF (right) cell lysates following 3 days of treatment with NaCl (Cl), Na2HB (HB), DMSO (<bold>D</bold>), or ethyl 2HB (Et). ‘+’ indicates positive control sample. Amount of protein loaded in each well is indicated above. Total protein staining and histone methylation markers displayed. For all western blots, total protein for each well was detected using REVERT total protein stain. (<bold>F</bold>) Quantification from two independent assays of OXPHOS antibody cocktail western blots using lysates from MEFs treated with 2HB for three days. No observed change to any respiratory chain complex from 2HB treatment is suggested.</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Raw data for <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-92707-fig5-figsupp1-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5s1sdata2"><label>Figure 5—figure supplement 1—source data 2.</label><caption><title>Labeled western blots.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92707-fig5-figsupp1-data2-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig5s1sdata3"><label>Figure 5—figure supplement 1—source data 3.</label><caption><title>Unlabeled western blots.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92707-fig5-figsupp1-data3-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92707-fig5-figsupp1-v2.tif"/></fig></fig-group><p>We hypothesized that the increased oxidative capacity induced by 2HB was dependent upon SIRT4 stimulation and activity of the BCAA degradation pathway. To address this possibility, we transfected C2C12s and MEFs with siRNA against SIRT4, BCKDHA, or non-targeting control. Cells were then cultured overnight in media supplemented with 500 μM Na2HB or NaCl, then subjected to a mitochondrial stress test. As before, both MEFs and C2C12s treated with 2HB exhibited an increased basal and maximal OCR (<xref ref-type="fig" rid="fig5">Figure 5C and D</xref>). Transfection with siRNA against SIRT4 reduced both basal and maximal OCR and abolished the effect of 2HB (<xref ref-type="fig" rid="fig5">Figure 5C and D</xref>). Transfection with siRNA against BCKDHA induced a less drastic reduction to basal and maximal OCR, but also showed no response to 2HB treatment (<xref ref-type="fig" rid="fig5">Figure 5C and D</xref>). These data show that SIRT4 and the BCAA degradation pathway, including the early step catalyzed by BCKDHA, is critical to the increased oxidative capacity induced by 2HB treatment.</p></sec><sec id="s2-11"><title>2HB-induced increase to oxidative capacity is maintained with chronic treatment</title><p>We were interested in whether the increase to cellular OCR would be maintained with chronic treatment. MEFs and C2C12s were treated with fresh media containing 500 μM of Na2HB or NaCl control daily for three days and assays run on the fourth day. We found chronic treatment with 2HB to result in increased maximum OCR in seahorse assays, to a similar effect size as overnight treatment (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>). We were interested if other mechanisms could be at play with chronic 2HB treatment. 2HB has been reported to promote cervical tumour cell survival via stimulation of the methyltransferase DOT1L (<xref ref-type="bibr" rid="bib20">Liu et al., 2018</xref>). We therefore investigated the potential for epigenetic regulation as a mechanism to explain the observed change in cellular oxidative capacity. However, we found no change to H3K79me3 signal in isolated histones after three days of 2HB treatment (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C, D</xref>). Neither C2C12s or MEFs exhibited any change to H3K27me3, H3K9me2, or H3K4me3, also suggesting no significant regulation of KDMs from three days of 2HB treatment (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C, D</xref>). Finally, we found no change to the expression levels of respiratory chain protein complexes I-V using an OXPHOS antibody cocktail (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1E, F</xref>). These data do not support epigenetic regulation or mitochondrial biogenesis as mechanistic alternatives to SIRT4-dependent upregulation of BCAA degradation pathway for metabolic responses to chronic 2HB treatment.</p></sec><sec id="s2-12"><title>Repeated 2HB treatment replicates in vitro mechanisms</title><p>We next aimed to find evidence for mechanisms leading to the increased oxidative capacity in mice treated with 1 mmol/kg 2HB for one week. We focused analysis on the soleus muscle, as skeletal muscle accounts for the majority of BCAA degradation in the body and the oxidative muscle fibers found in soleus muscle possess greater mitochondrial content for BCAA degradation capacity (<xref ref-type="bibr" rid="bib26">Neinast et al., 2019</xref>). We found that soleus muscles from mice treated with 2HB for 4 days exhibited increased ADPr in cytoplasmic extracts, but reduced ADPr in nuclear extracts (<xref ref-type="fig" rid="fig6">Figure 6A</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>). We repeated the poly/mono-ADPr and C/EBPβ immunoprecipitation experiments with soleus muscle nuclear extracts. We found that extracts from 2HB-treated mice exhibited reduced C/EBPβ ADPr (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). Accordingly, we find the soleus from mice treated with 2HB for 1 week to exhibit increased gene expression of BCAT2, BCKDHA, and PCCA compared with controls (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). We found increased protein expression of PCCA in 2HB-treated soleus lysates (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). Further, we found increased BCKDHA protein expression and reduced the amount of BCKDHA phosphorylation at S293 in soleus samples, indicating increased flux through the BCAA degradation pathway (<xref ref-type="fig" rid="fig6">Figure 6E</xref>). No changes to BCKDHA expression or phosphorylation were observed in extensor digitorum longus (EDL) lysates (<xref ref-type="fig" rid="fig6">Figure 6F</xref>). These data support the mechanisms of 2HB-induced changes to metabolism found in vitro as being plausible in vivo and support the soleus as a site of response to exogenous 2HB.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Mice treated with 2-hydroxybutyrate show functional responses intrinsic to skeletal muscle.</title><p>Data come from mice treated for four days with 1 mmol/kg NaCl or Na2HB with harvest of soleus and EDL skeletal muscle on the fifth day. (<bold>A</bold>) Representative western blots and quantification for total protein ADP ribosylation from cytoplasmic and nuclear extracts of soleus muscle. (<bold>B</bold>) Immunoprecipitation was conducted on soleus nuclear extracts using either antibody against C/EBPβ or poly-ADP ribose, with resultant membranes probed using the opposite antibody. Total C/EBPβ and histone 3 were detected in input samples. For A,B, N=6, Student’s t-test, * p0.05, ** p&lt;0.01. (<bold>C</bold>) RT-qPCR of soleus muscle. N=4, Sidak multiple comparisons test * p&lt;0.05. Representative western blots displayed using (<bold>D,E</bold>) soleus and (<bold>F</bold>) EDL lysates collected after incremental exercise tests showing total PCCA, BCKDHA, and BCKDHA phosphorylated at S293. N=10, student’s t-test, * p&lt;0.05. Ex vivo contractility analysis was conducted on freshly dissected muscle. (<bold>G</bold>) Force frequency curve, Sidak’s multiple comparisons test found no differences. (<bold>H</bold>) Force production during fatigue protocol with linear regression line displayed. Slopes of linear regression lines are significantly different; F test *** p&lt;0.001. (<bold>I</bold>) Time-to-event analysis displaying the number of stimulations in the fatigue protocol for the force output of each muscle to reach 50% of the initial force, log-rank test, ** p&lt;0.01. N=7–8 for soleus, N=5 for EDL. For (<bold>G, H</bold>) mean ± SEM.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Raw data for <xref ref-type="fig" rid="fig6">Figure 6</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-92707-fig6-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig6sdata2"><label>Figure 6—source data 2.</label><caption><title>Labeled western blots.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92707-fig6-data2-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig6sdata3"><label>Figure 6—source data 3.</label><caption><title>Unlabeled western blots.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92707-fig6-data3-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92707-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Supplemental data regarding skeletal muscle response to 2-hydroxybutyrate treatment.</title><p>(<bold>A</bold>) Total protein stain for western blot membrane corresponding to <xref ref-type="fig" rid="fig6">Figure 6A</xref>. (<bold>B</bold>) Quantification and representative western blot using OXPHOS antibody cocktail detection of electron transport chain members in soleus lysates from mice treated with 1 mmol/kg of NaCl or Na2HB for 4 days. (<bold>C</bold>) Quantification and representative western blot of histone methylation markers in soleus muscle treated as in B. For B and C, N=6. Data are expressed as fold change relative to average signal for NaCl group on the same membrane.</p><p><supplementary-material id="fig6s1sdata1"><label>Figure 6—figure supplement 1—source data 1.</label><caption><title>Raw data for <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-92707-fig6-figsupp1-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig6s1sdata2"><label>Figure 6—figure supplement 1—source data 2.</label><caption><title>Labeled western blots.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92707-fig6-figsupp1-data2-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig6s1sdata3"><label>Figure 6—figure supplement 1—source data 3.</label><caption><title>Unlabeled western blots.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92707-fig6-figsupp1-data3-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92707-fig6-figsupp1-v2.tif"/></fig></fig-group><p>As was observed in vitro, there was no change to protein expression of mitochondrial complexes I-V by western blot, indicating mitochondrial biogenesis as an unlikely explanation for the changes to oxidative capacity (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B</xref>). We also assessed histone methylation by western blot and found no change to soleus H3K27me3, H3K79me3, or H3K4me3 after one week of treatment (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1C</xref>).</p></sec><sec id="s2-13"><title>2HB improves soleus muscle resistance to fatigue</title><p>We hypothesized that the improved performance on exercise tests provided by 2HB was dependent upon changes intrinsic to oxidative skeletal muscle, which exhibits the increased activation and expression of BCAA degradation factors. To investigate, we conducted ex vivo contractility analysis of skeletal muscle isolated from mice treated with 1 mmol/kg/day Na2HB or NaCl control for four days. Each muscle was stimulated to produce a force-frequency curve, followed by a fatigue-inducing protocol. Soleus and EDL reached a peak specific force of approximately 200–270 kN/m<sup>2</sup> and 400 kN/m<sup>2</sup> respectively, with a trend towards reduced force production in 2HB-treated soleus (<xref ref-type="fig" rid="fig6">Figure 6G</xref>). Soleus muscles from 2HB treated mice demonstrated a slower rate of fatigue; the median number of stimulations required to reduce force production by 50% increased from 51 in controls to 70 in 2HB-treated soleus muscles (<xref ref-type="fig" rid="fig6">Figure 6HI</xref>). EDL from 2HB-treated mice performed similar to controls in the fatigue protocol (<xref ref-type="fig" rid="fig6">Figure 6H,I</xref>). These data demonstrate a functional change intrinsic to the skeletal muscle of 2HB-treated mice, specific to oxidative muscle groups.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>2HB has to date been described as a waste product that is released into the circulation during periods of metabolic or oxidative stress, for example, in acute infection, or post-exercise (<xref ref-type="bibr" rid="bib25">Morville et al., 2020</xref>; <xref ref-type="bibr" rid="bib8">Contrepois et al., 2020</xref>; <xref ref-type="bibr" rid="bib4">Bruzzone et al., 2020</xref>). Here, we describe an axis of cellular responses to increased levels of 2HB which regulate the BCAA degradation pathway. We find that exogenous 2HB treatment can recapitulate the effects of short-term exercise training in mice, via improving the fatigue resistance of oxidative skeletal muscle. These data provide insight into novel mechanisms involved in physiological changes to metabolism during exercise training.</p><p>The accumulation of 2HB is dependent upon the metabolic balance of 2 KB. We demonstrate that 2 KB is a suitable fuel for mitochondrial oxidation, dependent upon an intact BCAA degradation pathway (<xref ref-type="fig" rid="fig3">Figure 3</xref>). We found that PCC was required for 2 KB oxidation, while the BCKDH complex was dispensable. This is in line with data showing that pyruvate dehydrogenase may also oxidize 2 KB, although this too has been shown to be dispensable (<xref ref-type="bibr" rid="bib41">Thompson Legault et al., 2015</xref>; <xref ref-type="bibr" rid="bib38">Steele et al., 1984</xref>; <xref ref-type="bibr" rid="bib28">Paxton et al., 1986</xref>). As the capacity for 2 KB oxidation will modify 2HB production, future work interested in the presented 2HB-dependent mechanism should carefully consider the expression of pyruvate dehydrogenase and BCKDH in the tissue of interest as well as the metabolic environment guiding flux through these enzymes. Alternatively, 2 KB may be reduced by LDH to 2HB. The balance of oxidation versus reduction likely depends on cellular demand for NADH, oxygen availability, and capacity within the BCAA degradation pathway (<xref ref-type="bibr" rid="bib1">Anderson et al., 2017</xref>; <xref ref-type="bibr" rid="bib48">Zaganjor et al., 2021</xref>; <xref ref-type="bibr" rid="bib23">Min et al., 2018</xref>; <xref ref-type="bibr" rid="bib46">White et al., 2018</xref>).</p><p>We find that 2HB is a poor substrate for LDH oxidation, supporting the well-described accumulation of 2HB post-exercise, with a slow return to homeostatic levels (<xref ref-type="fig" rid="fig2">Figures 2</xref> and <xref ref-type="fig" rid="fig3">3</xref>; <xref ref-type="bibr" rid="bib34">Sato et al., 2022</xref>; <xref ref-type="bibr" rid="bib25">Morville et al., 2020</xref>). Together, these observations are consistent with the accumulation of 2HB as an indicator of saturated capacity for 2 KB oxidation via the BCAA degradation pathway. Interestingly, this pattern is mirrored by the BCHA, 2-hydroxyisocaproate, 2-hydroxy-3-methylvalerate, and 2-hydroxyisovalerate in human plasma metabolomics following exercise (<xref ref-type="fig" rid="fig2">Figure 2</xref>). The BCHA are rare metabolites, which is consistent with our observation of very low relative reaction rates for the reduction of BCKA by LDH (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Further, we were unable to observe significant oxidation of the BCHA in isolated LDH assays (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>), which is consistent with the pattern of accumulation without return to baseline for all the hydroxy acids (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Thus, we propose that the reduction of 2 KB and BCKA indicate oversaturation of the BCAA degradation pathway, leading to the LDH-dependent production of 2HB or BCHA that are metabolically stubborn and tend to accumulate.</p><p>It is reported that the liver is the major producer of circulating 2HB (<xref ref-type="bibr" rid="bib34">Sato et al., 2022</xref>), which would suggest that many tissues receive external 2HB, and that therefore the balance of 2HB metabolism will depend upon 2HB oxidation. LDH isolated from bovine heart had a greater capacity for oxidation of 2HB than LDH isolated from bovine skeletal muscle (<xref ref-type="fig" rid="fig3">Figure 3</xref>), suggesting that <italic>LDHB</italic> gene expression may provide an advantage when metabolising exogenous 2HB. Skeletal muscle expression of <italic>LDHB</italic> was previously reported to be induced by exercise training, and to be dependent upon peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α), and that <italic>LDHB</italic> expression was required for generating an exercise training benefit (<xref ref-type="bibr" rid="bib19">Liang et al., 2016</xref>). Together, this would suggest that improved capacity for metabolising 2HB is common to the progression of endurance training. Since we observed no induction to PGC-1α gene expression or mitochondrial biogenesis (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>), treatment with exogenous 2HB does not appear to replicate all exercise training responses in oxidative skeletal muscle. It is possible that 2HB-induced effects on BCAA metabolism occur in an early stage of skeletal muscle endurance training, and that additional signals are required to continue training progression.</p><p>We found that the in vitro improvement to oxidative capacity induced by 2HB was dependent upon expression of BCKDHA and SIRT4 (<xref ref-type="fig" rid="fig5">Figure 5</xref>). SIRT4 has been previously reported to produce greater expression and activation of BCAA degradation pathway members (<xref ref-type="bibr" rid="bib1">Anderson et al., 2017</xref>; <xref ref-type="bibr" rid="bib48">Zaganjor et al., 2021</xref>), along with C/EBPβ (<xref ref-type="bibr" rid="bib33">Ryu et al., 2018</xref>), making this a logical signaling axis for 2HB response. SIRT4 is relatively unique in its preference for ADP-ribosylation activity as opposed to the de-acylation activity of other sirtuins (<xref ref-type="bibr" rid="bib17">Kumar and Lombard, 2015</xref>), providing further support for the role of SIRT4 in the presented mechanism. However, future work should investigate the role of other sirtuins, particularly the other mitochondrial sirtuins SIRT3 and SIRT5, as these are often more prevalent than SIRT4 and modify a large range of target proteins.</p><p>Increased flux in the BCAA degradation pathway is reflected by a reduced proportion of BCKDHA phosphorylation (<xref ref-type="bibr" rid="bib46">White et al., 2018</xref>; <xref ref-type="bibr" rid="bib27">Paxton and Harris, 1984</xref>), which we observe in the soleus of 2HB-treated mice post-exercise (<xref ref-type="fig" rid="fig6">Figure 6</xref>). BCKDHA phosphorylation by BCKDH kinase is inhibited by BCKA. Thus, the reduced BCKDHA phosphorylation is consistent with the increase to BCKA observed in oxidative red gastrocnemius muscle (<xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). That we observe reduced levels of muscular BCHA despite the increase to BCKA levels, without an increase in release of BCKA to the serum, suggests an increase to the oxidative muscle capacity for BCKA oxidation (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><p>Together, these data form a logical feedback loop where accumulation of 2HB provides negative feedback to reduce BCAA degradation at the stage of BCAT. Acutely, this would reduce competition for 2 KB in the BCAA degradation pathway by slowing conversion of BCAA to keto acids. A sufficiently large acute dose of 2HB may limit mitochondrial fuel by inhibiting BCAT. This model is consistent with the observed rapid increase to NAD+/NADH ratio in MEFs and C2C12s treated with 2HB in culture (<xref ref-type="fig" rid="fig4">Figure 4</xref>). We show that this metabolic effect will lead to transcriptional feedback; an increase BCAA and 2 KB oxidation capacity will in the long-term reduce the production of 2HB and BCHA, as observed in red gastrocnemius post-exercise in 2HB-treated mice (<xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). That we observe similar transcriptional regulation, changes to BCKDHA phosphorylation, and changes to oxidative metabolism phenotypes in vivo suggests that a similar mechanism is occurring in response to intraperitoneal injections of 2HB. In the case of exercise, the physiological accumulation of 2HB would occur during high metabolic demand when mitochondrial fuel supply may be sensitive to the 2HB despite a potentially lower concentration than the exogenous doses used in this study. This is supported by the lack of additive effect on mouse ΔVO<sub>2</sub>max when exogenous 2HB treatment was combined with exercise training (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><p>Overall, this study presents an axis of cellular response to 2HB and presents a functional response to repeated 2HB treatment in the form of improved exercise performance and resistance to fatigue in oxidative murine skeletal muscle. Further work investigating cellular responses to accumulated 2HB are warranted as this metabolite accumulates in the circulation of individuals with infection and metabolic disorders (<xref ref-type="bibr" rid="bib4">Bruzzone et al., 2020</xref>; <xref ref-type="bibr" rid="bib11">Gall et al., 2010</xref>; <xref ref-type="bibr" rid="bib7">Cobb et al., 2016</xref>).</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Animals</title><p>Male C57Bl/6 mice were purchased from Janvier Labs (C57Bl/6JRj) and housed at Karolinska Institutet under specific pathogen-free conditions. All experiments and protocols were approved by the regional ethics committee of Northern Stockholm (Ref. 19683–2021). Six-week-old mice were housed for 2 weeks prior to any experimental procedures to acclimate to the new housing. Mice were randomly assigned to treatment groups following acclimation. At experimental endpoint mice were terminated by carbon dioxide. Blood was collected via cardiac puncture and spun in tabletop centrifuge to remove coagulated components, yielding serum. Collected tissue was snap-frozen in liquid nitrogen.</p></sec><sec id="s4-2"><title>Incremental exercise protocols</title><p>An enclosed chamber treadmill (Columbus Instruments) set at 10° incline was used for all exercise and respiration measurements. Eight-week-old mice were acclimated to the treadmill progressively over 4 days in a standardized protocol across all mice:</p><p>Day 1: mice are placed on stationary treadmill for 5 min. Starting at 6 m/min for 3 min, speed is increased 3 m/min every 3 minutes. Completed after 3 min at 12 m/min.</p><p>Day 2: mice are placed on stationary treadmill for 3 min. Starting at 6 m/min for 3 min, speed is increased 3 m/min every 3 min. Completed after 3 min at 15 m/min.</p><p>Day 3: mice are placed on stationary treadmill for 3 min. Starting at 9 m/min for 3 min, speed is increased 3 m/min every 3 minutes. Completed after 3 min at 18 m/min.</p><p>Day 4: mice are placed on stationary treadmill for 3 min. Starting at 9 m/min for 3 min, speed is increased 3 m/min every 3 min. Completed after 3 min at 21 m/min.</p><p>Acclimation was completed at least 48 hr prior to any incremental exercise tests concurrent with measurements of O<sub>2</sub> and CO<sub>2</sub> respiration. Incremental exercise tests began with a 5-min settling period, 3 min of measurement with the treadmill at rest, followed by an initial treadmill speed of 6 m/min, after which the speed was increased by 3 m/min every 3 min. Exercise and measurements of oxygen consumption continued until mouse exhaustion, defined as when the mouse refused to run after 10 continuous seconds in contact with an electrical grid providing a 1.22 mAmp stimulus at a rate of 2 Hz. <xref ref-type="fig" rid="fig2">Figure 2</xref> exercise held the treadmill at 18 m/min for 30 min instead of continuing until exhaustion. Oxygen and carbon dioxide was monitored using a carbon dioxide and paramagnetic oxygen sensor within an OxyMax system (Columbus Instruments). Measurements were collected every 15 s. Basal VO<sub>2</sub> measured while the treadmill was at rest was used to calculate the change to VO<sub>2</sub> (ΔVO<sub>2</sub>) throughout the exercise protocol. ΔVO<sub>2</sub>max was defined as the maximum increase to VO<sub>2</sub> above baseline achieved during the incremental exercise protocol.</p></sec><sec id="s4-3"><title>Cells</title><p>Mouse embryonic fibroblasts (MEFs) were originally derived as described previously (<xref ref-type="bibr" rid="bib37">Sim et al., 2018</xref>). C2C12 murine myoblasts were a gift from Dr. Jorge Ruas. Cells were cultured in Dulbecco’s modified eagle medium (DMEM) supplemented with 10% fetal bovine serum and penicillin/streptomycin. Cells were cultured with 5% CO<sub>2</sub>, humidity and temperature control, in a cell culture incubator in normoxia (21% O<sub>2</sub>, Sanyo).</p></sec><sec id="s4-4"><title>Compounds and drugs</title><p>Cell culture media was supplemented as indicated with sodium salts of metabolites, including Na2-hydroxybutyrate and Na2-ketobutyrate and NaCl as a salinity control. Na2HB and NaCl were dissolved in sterile PBS and administered to mice at a concentration of 250 mM with a dosage of 1 mmol/kg. Aminooxyacetic acid (AOA; Sigma) was used as an inhibitor of aminotransferases, and the DOT1L inhibitor EPZ004777 (MedChemExpress).</p></sec><sec id="s4-5"><title>Expression plasmids and transfections</title><p>MEF and C2C12 cells were transiently transfected using Lipofectamine 2000 (Thermo Fisher) with 20 ng per expression plasmid for 2x10<sup>4</sup> cells per well in a 96-well plate. Cells were treated with transfection mixes for 8–24 hr before further treatment. Knockdown experiments used dicer-substrate siRNA (IDT DNA) against BCKDHA, PCCA, or SIRT4, sequences in Supplementary Information. Knockdown was confirmed by RT-qPCR 24 hr after transfection.</p></sec><sec id="s4-6"><title>In vitro oxygen consumption rate and extracellular acidification rate</title><p>Cellular oxygen consumption rate (OCR) was measured using a Seahorse Extracellular Flux Analyser XF96 (Agilent). MEFs or C2C12s were seeded with 2x10<sup>4</sup> cells per well on the day prior to assay. XF DMEM media (Agilent) was supplemented with 10 mM glucose, 2 mM of L-glutamine, and 1 mM Na pyruvate as indicated. Cells were subjected to a ‘mitochondrial stress test’ protocol, involving sequential injection of 2.5 µM oligomycin, 1 µM FCCP, and a combination of 1 µM antimycin A with 100 nM rotenone. Cells were also subjected to a standard ‘glycolysis stress test’ protocol with quantification of the extracellular acidification rate (ECAR), involving sequential injection of 10 mM glucose, 2.5 μM oligomycin, and 50 mM 2-deoxyglucose. Listed concentrations are the final concentrations for each compound. All compounds added in seahorse assays were acquired from Sigma. For experiments acutely treating cells with metabolites within the seahorse instrument, OCR and ECAR values were normalised to baseline measures. For experiments investigating the effects of treatments prior to the assay, OCR and ECAR values were normalized to protein levels within each well quantified by BCA assay (Abcam) conducted after the Seahorse assay.</p></sec><sec id="s4-7"><title>Western blotting</title><p>Total protein was isolated from cells or mouse tissue using RIPA buffer (Thermo Fisher), or lysates were enriched for histone proteins using Histone Extraction Kit (Abcam), or cytoplasmic and nuclear extracts were isolated using NE-PER Nuclear and Cytoplasmic Extraction Reagents (ThermoFisher), each according to manufacturer instructions. Tissues were homogenized using a glass dounce homogenizer (Active Motif) and kept on ice during homogenization. Proteins were separated in SDS-PAGE, transferred onto PVDF membrane, and probed with antibodies against C/EBPβ (Thermo Fisher, MA1-827), BCKDHA (Thermo Fisher, PA597248), BCAT2 (abcam, ab95976), DDK tag (Origene, TA50011-100), Histone 3 (abcam, ab12079), H3K4me3 (Cell Signaling Technologies, 62255), H3K9me2 (Cell Signaling Technologies, 4658), H3K27me3 (Cell Signaling Technologies, 9733), H3K79me3 (Cell Signaling Technologies, 4260), OXPHOS antibody cocktail (abcam, ab110413), or Poly/Mono ADP-ribose (Cell Signaling Technologies, 83732) and detected using infrared labeled secondary antibody and an ODYSSEY imaging system (LICOR).Antibody signal was normalized to total protein quantified by REVERT total protein stain (LICOR) or appropriate loading control. Western blot data were analyzed using Image Studio Lite software (Image Studio Lite).</p></sec><sec id="s4-8"><title>RT-qPCR</title><p>Total RNA was extracted using Trizol (Thermo Fisher) according to manufacturer instructions. One microgram of RNA was reverse transcribed using iScript cDNA synthesis kit (BioRad) in a total volume of 20 µL. Real time RT-RT-qPCR was applied to quantify mRNA (7500 Fast Real-Time PCR system, Applied Biosciences Inc, or StepOnePlus Real-time PCR system, Thermo Fisher). Primers are listed in Supplementary Information. Reactions were performed in 96-well MicroAmp Optical plates in duplicate, using SsoAdvanced Universal SYBR Green supermix (BioRad). Gene expression was normalized to <italic>HPRT</italic> unless otherwise indicated.</p></sec><sec id="s4-9"><title>Metabolomics analysis</title><p>Metabolomics data from <xref ref-type="bibr" rid="bib34">Sato et al., 2022</xref> and <xref ref-type="bibr" rid="bib32">Rundqvist et al., 2020</xref> was selected based on relevance to our hypotheses. Data was scaled before correlation analysis and partial correlation coefficient calculated to quantify metabolite pair correlations. Correlation analysis was conducted using the MetScape correlation calculator (<xref ref-type="bibr" rid="bib16">Karnovsky et al., 2012</xref>).</p><p>Metabolomics related to <xref ref-type="fig" rid="fig2">Figure 2</xref> was performed by Metabolon. Peak area data was subjected to feature-wise normalization using standard scaling or log-transformation to optimize data column normality (<xref ref-type="bibr" rid="bib29">Pedregosa et al., 2011</xref>). Normalization and scaling were conducted separately for serum, red gastrocnemius, and white gastrocnemius data. Exercise and sham treatments for metabolomics experiments occurred inside of sealed treadmills with respiration measurements taken throughout exercise. As treatment altered exercise performance, for some analyses metabolite data was adjusted based on multiple linear regression of respiration parameters. Metabolomics data analysis was conducted using custom python code. Statistical comparisons conducted using statsmodels python package (<xref ref-type="bibr" rid="bib35">Seabold and Perktold, 2010</xref>). Heatmaps produced using seaborn python package (<xref ref-type="bibr" rid="bib45">Waskom, 2021</xref>) or Prism9 (GraphPad).</p></sec><sec id="s4-10"><title>LDH, BCAT, KDM6A, Prolyl hydroxylase activity assays</title><p>Activity of LDH was assessed using of isolated bovine heart LDH (Sigma), isolated bovine muscle LDH (Sigma), or mouse tissue lysates as described previously (<xref ref-type="bibr" rid="bib40">Talaiezadeh et al., 2015</xref>). Briefly, one unit of isolated LDH enzyme or 5 μg of tissue lysate was added to a solution of substrate with 2 mM NAD +for oxidation reactions or substrate with 0.5 mM NADH for reduction reactions, in 20 mM Tris-HCl buffer pH 8.0. Activity of BCAT was assessed using recombinant human BCAT2 (rhBCAT2; R&amp;D Systems; <xref ref-type="bibr" rid="bib9">Cooper et al., 2002</xref>). Briefly, the reaction catalyzed by BCAT2 transferring an amino group from leucine (Leu) to αKG, producing ketoisocaproate (KIC) and glutamate (Glu) respectively, is coupled to the NADH-consuming reaction catalyzed by leucine dehydrogenase from <italic>Bacillus cereus</italic> (LeuDH; Sigma), which converts KIC back to Leu. The reaction mixture consisted of 5 μM pyridoxal phosphate, 50 mM ammonium sulfate, 5 mM DTT, a range of αKG, 10 mM Leu, 0.5 mM NADH, and a range of Na2HB in 100 mM potassium phosphate buffer pH 7.4. One unit of LeuDH along with 100 ng of rhBCAT2 was added to the reaction mixture to initiate the reaction. Upon addition of enzyme, reaction plates were immediately transferred to a plate reader (Synergy Biotek) set at 37 °C and absorbance at 340 nm quantified every 30 s for 10 min. The initial maximum rate of reaction following any present lag phase was abstracted as the reaction rate.</p><p>Activity assays for human KDM6A and the prolyl hydroxylases, HIFP4H1 and HIFP4H2, were conducted as described previously (<xref ref-type="bibr" rid="bib6">Chakraborty et al., 2019</xref>; <xref ref-type="bibr" rid="bib13">Hirsilä et al., 2003</xref>; <xref ref-type="bibr" rid="bib24">Minogue et al., 2023</xref>).</p></sec><sec id="s4-11"><title>Skeletal muscle ex vivo contractile function and fatigue</title><p>Skeletal muscle was prepared and assessed as described previously (<xref ref-type="bibr" rid="bib5">Chaillou et al., 2017</xref>). Briefly, the soleus and EDL muscle were excised under dissection microscope from the right hindlimb with proximal and distal tendons kept intact. Excess adipose tissue was manually cleaned from the muscles and tendons were tied with a braided silk thread and mounted in a 15 mL stimulation chamber between a force transducer and an adjustable holder (World Precision Instruments). Muscles were submerged in a Tyrode solution containing (in mmol/L): 121 NaCl, 5 KCl, 1.8 CaCl<sub>2</sub>, 0.1 EDTA, 0.5 MgCl<sub>2</sub>, 0.4 NaH<sub>2</sub>PO<sub>4</sub>, 5.5 glucose, and 24 NaHCO<sub>3</sub>. The force stimulation chamber was set to 31 °C and gassed with 95% O<sub>2</sub> 5% CO<sub>2</sub> for a pH of 7.4. Each mounted muscle was adjusted to the length at which the highest twitch force was recorded and then allowed to rest for 15 min. The force frequency relationship was determined through stimulations at the following frequencies: 1 (twitch), 10, 15, 20, 30, 50, 70, 100, and 120 Hz for soleus, and 1, 20, 30, 40, 50, 70, 100, 120, and 150 Hz for EDL. The stimuli were interspaced by 1 min of rest. Upon completion, the muscle was allowed to rest for 7 min before starting a fatigue protocol consisting of 100 stimulations (70 Hz, 600 ms train duration, 2 s interval duration) for the soleus or 50 stimulation (100 Hz, 300 ms train duration, 2 s interval duration) for the EDL. Muscle recovery was determined at 1, 2, 5, and 10 min after the final tetanic stimulation at the same stimulation frequency. Absolute force was expressed in millinewton (mN). Specific force (kN/m<sup>2</sup>) was calculated by dividing the absolute force by the muscle cross sectional area, the latter determined by dividing the muscle mass (with tendons removed) by muscle length and density, assuming a density of 1.06 g/cm<sup>3</sup>.</p></sec><sec id="s4-12"><title>Statistical analysis</title><p>Data was visualized and statistical analyses conducted in Prism 9 (GraphPad). Statistical tests and replicates are stated in figure legends. Plotted data represent biological replicates of either distinct animals for in vivo and ex vivo experiments, or independent assays for in vitro experiments.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con8"><p>Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con9"><p>Investigation</p></fn><fn fn-type="con" id="con10"><p>Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con11"><p>Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con12"><p>Formal analysis, Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con13"><p>Formal analysis, Supervision, Funding acquisition, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con14"><p>Conceptualization, Resources, Formal analysis, Funding acquisition, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>This study was performed in accordance with the recommendations for ethical experimentation of Swedish and EU laws and regulations. All animal handling was performed in accordance with approved institutional animal care protocols. Animal protocol was approved by the Committee on Ethics of Animal Experiments of the Ethical Review Board of Northern Stockholm (Ref. 19683-2021) and the Swedish Ministry of Agriculture.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>2HB and 2KB IC50 for isolated PHD and KDM enzymes.</title></caption><media xlink:href="elife-92707-supp1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-92707-mdarchecklist1-v2.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analysed and plotted to produce this manuscript are included in the source data file(s). Original code used to analyse metabolomics data is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/bjwadswo/JohnsonLab_Wadsworth-et-al_2HB-Metabolomics">https://github.com/bjwadswo/JohnsonLab_Wadsworth-et-al_2HB-Metabolomics</ext-link> (copy archived at <xref ref-type="bibr" rid="bib44">Wadsworth, 2024</xref>).</p></sec><ack id="ack"><title>Acknowledgements</title><p>We acknowledge Dr. Cristina M. Branco of Queen's University, Belfast, for her role and support in the supervision and funding of Pedro P. Cunha.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>KA</given-names></name><name><surname>Huynh</surname><given-names>FK</given-names></name><name><surname>Fisher-Wellman</surname><given-names>K</given-names></name><name><surname>Stuart</surname><given-names>JD</given-names></name><name><surname>Peterson</surname><given-names>BS</given-names></name><name><surname>Douros</surname><given-names>JD</given-names></name><name><surname>Wagner</surname><given-names>GR</given-names></name><name><surname>Thompson</surname><given-names>JW</given-names></name><name><surname>Madsen</surname><given-names>AS</given-names></name><name><surname>Green</surname><given-names>MF</given-names></name><name><surname>Sivley</surname><given-names>RM</given-names></name><name><surname>Ilkayeva</surname><given-names>OR</given-names></name><name><surname>Stevens</surname><given-names>RD</given-names></name><name><surname>Backos</surname><given-names>DS</given-names></name><name><surname>Capra</surname><given-names>JA</given-names></name><name><surname>Olsen</surname><given-names>CA</given-names></name><name><surname>Campbell</surname><given-names>JE</given-names></name><name><surname>Muoio</surname><given-names>DM</given-names></name><name><surname>Grimsrud</surname><given-names>PA</given-names></name><name><surname>Hirschey</surname><given-names>MD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>SIRT4 Is a Lysine Deacylase that Controls Leucine Metabolism and Insulin Secretion</article-title><source>Cell Metabolism</source><volume>25</volume><fpage>838</fpage><lpage>855</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2017.03.003</pub-id><pub-id pub-id-type="pmid">28380376</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berton</surname><given-names>R</given-names></name><name><surname>Conceição</surname><given-names>MS</given-names></name><name><surname>Libardi</surname><given-names>CA</given-names></name><name><surname>Canevarolo</surname><given-names>RR</given-names></name><name><surname>Gáspari</surname><given-names>AF</given-names></name><name><surname>Chacon-Mikahil</surname><given-names>MPT</given-names></name><name><surname>Zeri</surname><given-names>AC</given-names></name><name><surname>Cavaglieri</surname><given-names>CR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Metabolic time-course response after resistance exercise: A metabolomics approach</article-title><source>Journal of Sports Sciences</source><volume>35</volume><fpage>1211</fpage><lpage>1218</lpage><pub-id pub-id-type="doi">10.1080/02640414.2016.1218035</pub-id><pub-id pub-id-type="pmid">27686013</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brooks</surname><given-names>GA</given-names></name><name><surname>Osmond</surname><given-names>AD</given-names></name><name><surname>Arevalo</surname><given-names>JA</given-names></name><name><surname>Duong</surname><given-names>JJ</given-names></name><name><surname>Curl</surname><given-names>CC</given-names></name><name><surname>Moreno-Santillan</surname><given-names>DD</given-names></name><name><surname>Leija</surname><given-names>RG</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Lactate as a myokine and exerkine: drivers and signals of physiology and metabolism</article-title><source>Journal of Applied Physiology</source><volume>134</volume><fpage>529</fpage><lpage>548</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00497.2022</pub-id><pub-id pub-id-type="pmid">36633863</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruzzone</surname><given-names>C</given-names></name><name><surname>Bizkarguenaga</surname><given-names>M</given-names></name><name><surname>Gil-Redondo</surname><given-names>R</given-names></name><name><surname>Diercks</surname><given-names>T</given-names></name><name><surname>Arana</surname><given-names>E</given-names></name><name><surname>García de Vicuña</surname><given-names>A</given-names></name><name><surname>Seco</surname><given-names>M</given-names></name><name><surname>Bosch</surname><given-names>A</given-names></name><name><surname>Palazón</surname><given-names>A</given-names></name><name><surname>San Juan</surname><given-names>I</given-names></name><name><surname>Laín</surname><given-names>A</given-names></name><name><surname>Gil-Martínez</surname><given-names>J</given-names></name><name><surname>Bernardo-Seisdedos</surname><given-names>G</given-names></name><name><surname>Fernández-Ramos</surname><given-names>D</given-names></name><name><surname>Lopitz-Otsoa</surname><given-names>F</given-names></name><name><surname>Embade</surname><given-names>N</given-names></name><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Mato</surname><given-names>JM</given-names></name><name><surname>Millet</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>SARS-CoV-2 Infection Dysregulates the Metabolomic and Lipidomic Profiles of Serum</article-title><source>iScience</source><volume>23</volume><elocation-id>101645</elocation-id><pub-id pub-id-type="doi">10.1016/j.isci.2020.101645</pub-id><pub-id pub-id-type="pmid">33043283</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaillou</surname><given-names>T</given-names></name><name><surname>McPeek</surname><given-names>A</given-names></name><name><surname>Lanner</surname><given-names>JT</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Docetaxel does not impair skeletal muscle force production in a murine model of cancer chemotherapy</article-title><source>Physiological Reports</source><volume>5</volume><elocation-id>e13261</elocation-id><pub-id pub-id-type="doi">10.14814/phy2.13261</pub-id><pub-id pub-id-type="pmid">28583990</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakraborty</surname><given-names>AA</given-names></name><name><surname>Laukka</surname><given-names>T</given-names></name><name><surname>Myllykoski</surname><given-names>M</given-names></name><name><surname>Ringel</surname><given-names>AE</given-names></name><name><surname>Booker</surname><given-names>MA</given-names></name><name><surname>Tolstorukov</surname><given-names>MY</given-names></name><name><surname>Meng</surname><given-names>YJ</given-names></name><name><surname>Meier</surname><given-names>SR</given-names></name><name><surname>Jennings</surname><given-names>RB</given-names></name><name><surname>Creech</surname><given-names>AL</given-names></name><name><surname>Herbert</surname><given-names>ZT</given-names></name><name><surname>McBrayer</surname><given-names>SK</given-names></name><name><surname>Olenchock</surname><given-names>BA</given-names></name><name><surname>Jaffe</surname><given-names>JD</given-names></name><name><surname>Haigis</surname><given-names>MC</given-names></name><name><surname>Beroukhim</surname><given-names>R</given-names></name><name><surname>Signoretti</surname><given-names>S</given-names></name><name><surname>Koivunen</surname><given-names>P</given-names></name><name><surname>Kaelin</surname><given-names>WG</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate</article-title><source>Science</source><volume>363</volume><fpage>1217</fpage><lpage>1222</lpage><pub-id pub-id-type="doi">10.1126/science.aaw1026</pub-id><pub-id pub-id-type="pmid">30872525</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cobb</surname><given-names>J</given-names></name><name><surname>Eckhart</surname><given-names>A</given-names></name><name><surname>Motsinger-Reif</surname><given-names>A</given-names></name><name><surname>Carr</surname><given-names>B</given-names></name><name><surname>Groop</surname><given-names>L</given-names></name><name><surname>Ferrannini</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>α-Hydroxybutyric acid is a selective metabolite biomarker of impaired glucose tolerance</article-title><source>Diabetes Care</source><volume>39</volume><fpage>988</fpage><lpage>995</lpage><pub-id pub-id-type="doi">10.2337/dc15-2752</pub-id><pub-id pub-id-type="pmid">27208342</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Contrepois</surname><given-names>K</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Moneghetti</surname><given-names>KJ</given-names></name><name><surname>Hornburg</surname><given-names>D</given-names></name><name><surname>Ahadi</surname><given-names>S</given-names></name><name><surname>Tsai</surname><given-names>M-S</given-names></name><name><surname>Metwally</surname><given-names>AA</given-names></name><name><surname>Wei</surname><given-names>E</given-names></name><name><surname>Lee-McMullen</surname><given-names>B</given-names></name><name><surname>Quijada</surname><given-names>JV</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Christle</surname><given-names>JW</given-names></name><name><surname>Ellenberger</surname><given-names>M</given-names></name><name><surname>Balliu</surname><given-names>B</given-names></name><name><surname>Taylor</surname><given-names>S</given-names></name><name><surname>Durrant</surname><given-names>MG</given-names></name><name><surname>Knowles</surname><given-names>DA</given-names></name><name><surname>Choudhry</surname><given-names>H</given-names></name><name><surname>Ashland</surname><given-names>M</given-names></name><name><surname>Bahmani</surname><given-names>A</given-names></name><name><surname>Enslen</surname><given-names>B</given-names></name><name><surname>Amsallem</surname><given-names>M</given-names></name><name><surname>Kobayashi</surname><given-names>Y</given-names></name><name><surname>Avina</surname><given-names>M</given-names></name><name><surname>Perelman</surname><given-names>D</given-names></name><name><surname>Schüssler-Fiorenza Rose</surname><given-names>SM</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Ashley</surname><given-names>EA</given-names></name><name><surname>Montgomery</surname><given-names>SB</given-names></name><name><surname>Chaib</surname><given-names>H</given-names></name><name><surname>Haddad</surname><given-names>F</given-names></name><name><surname>Snyder</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Molecular choreography of acute exercise</article-title><source>Cell</source><volume>181</volume><fpage>1112</fpage><lpage>1130</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.04.043</pub-id><pub-id pub-id-type="pmid">32470399</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>AJL</given-names></name><name><surname>Conway</surname><given-names>M</given-names></name><name><surname>Hutson</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>A continuous 96-well plate spectrophotometric assay for branched-chain amino acid aminotransferases</article-title><source>Analytical Biochemistry</source><volume>308</volume><fpage>100</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1016/s0003-2697(02)00243-9</pub-id><pub-id pub-id-type="pmid">12234469</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foskolou</surname><given-names>IP</given-names></name><name><surname>Barbieri</surname><given-names>L</given-names></name><name><surname>Vernet</surname><given-names>A</given-names></name><name><surname>Bargiela</surname><given-names>D</given-names></name><name><surname>Cunha</surname><given-names>PP</given-names></name><name><surname>Velica</surname><given-names>P</given-names></name><name><surname>Suh</surname><given-names>E</given-names></name><name><surname>Pietsch</surname><given-names>S</given-names></name><name><surname>Matuleviciute</surname><given-names>R</given-names></name><name><surname>Rundqvist</surname><given-names>H</given-names></name><name><surname>McIntyre</surname><given-names>D</given-names></name><name><surname>Smith</surname><given-names>KGC</given-names></name><name><surname>Johnson</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The S enantiomer of 2-hydroxyglutarate increases central memory CD8 populations and improves CAR-T therapy outcome</article-title><source>Blood Advances</source><volume>4</volume><fpage>4483</fpage><lpage>4493</lpage><pub-id pub-id-type="doi">10.1182/bloodadvances.2020002309</pub-id><pub-id pub-id-type="pmid">32941648</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gall</surname><given-names>WE</given-names></name><name><surname>Beebe</surname><given-names>K</given-names></name><name><surname>Lawton</surname><given-names>KA</given-names></name><name><surname>Adam</surname><given-names>K-P</given-names></name><name><surname>Mitchell</surname><given-names>MW</given-names></name><name><surname>Nakhle</surname><given-names>PJ</given-names></name><name><surname>Ryals</surname><given-names>JA</given-names></name><name><surname>Milburn</surname><given-names>MV</given-names></name><name><surname>Nannipieri</surname><given-names>M</given-names></name><name><surname>Camastra</surname><given-names>S</given-names></name><name><surname>Natali</surname><given-names>A</given-names></name><name><surname>Ferrannini</surname><given-names>E</given-names></name><collab>RISC Study Group</collab></person-group><year iso-8601-date="2010">2010</year><article-title>alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population</article-title><source>PLOS ONE</source><volume>5</volume><elocation-id>e10883</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0010883</pub-id><pub-id pub-id-type="pmid">20526369</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawley</surname><given-names>JA</given-names></name><name><surname>Hargreaves</surname><given-names>M</given-names></name><name><surname>Joyner</surname><given-names>MJ</given-names></name><name><surname>Zierath</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Integrative Biology of Exercise</article-title><source>Cell</source><volume>159</volume><fpage>738</fpage><lpage>749</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.10.029</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirsilä</surname><given-names>M</given-names></name><name><surname>Koivunen</surname><given-names>P</given-names></name><name><surname>Günzler</surname><given-names>V</given-names></name><name><surname>Kivirikko</surname><given-names>KI</given-names></name><name><surname>Myllyharju</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor</article-title><source>The Journal of Biological Chemistry</source><volume>278</volume><fpage>30772</fpage><lpage>30780</lpage><pub-id pub-id-type="doi">10.1074/jbc.M304982200</pub-id><pub-id pub-id-type="pmid">12788921</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hopp</surname><given-names>AK</given-names></name><name><surname>Teloni</surname><given-names>F</given-names></name><name><surname>Bisceglie</surname><given-names>L</given-names></name><name><surname>Gondrand</surname><given-names>C</given-names></name><name><surname>Raith</surname><given-names>F</given-names></name><name><surname>Nowak</surname><given-names>K</given-names></name><name><surname>Muskalla</surname><given-names>L</given-names></name><name><surname>Howald</surname><given-names>A</given-names></name><name><surname>Pedrioli</surname><given-names>PGA</given-names></name><name><surname>Johnsson</surname><given-names>K</given-names></name><name><surname>Altmeyer</surname><given-names>M</given-names></name><name><surname>Pedrioli</surname><given-names>DML</given-names></name><name><surname>Hottiger</surname><given-names>MO</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Mitochondrial NAD<sup>+</sup> Controls Nuclear ARTD1-Induced ADP-Ribosylation</article-title><source>Molecular Cell</source><volume>81</volume><fpage>340</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2020.12.034</pub-id><pub-id pub-id-type="pmid">33450210</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Intlekofer</surname><given-names>AM</given-names></name><name><surname>Dematteo</surname><given-names>RG</given-names></name><name><surname>Venneti</surname><given-names>S</given-names></name><name><surname>Finley</surname><given-names>LWS</given-names></name><name><surname>Lu</surname><given-names>C</given-names></name><name><surname>Judkins</surname><given-names>AR</given-names></name><name><surname>Rustenburg</surname><given-names>AS</given-names></name><name><surname>Grinaway</surname><given-names>PB</given-names></name><name><surname>Chodera</surname><given-names>JD</given-names></name><name><surname>Cross</surname><given-names>JR</given-names></name><name><surname>Thompson</surname><given-names>CB</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Hypoxia induces production of L-2-Hydroxyglutarate</article-title><source>Cell Metabolism</source><volume>22</volume><fpage>304</fpage><lpage>311</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2015.06.023</pub-id><pub-id pub-id-type="pmid">26212717</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karnovsky</surname><given-names>A</given-names></name><name><surname>Weymouth</surname><given-names>T</given-names></name><name><surname>Hull</surname><given-names>T</given-names></name><name><surname>Tarcea</surname><given-names>VG</given-names></name><name><surname>Scardoni</surname><given-names>G</given-names></name><name><surname>Laudanna</surname><given-names>C</given-names></name><name><surname>Sartor</surname><given-names>MA</given-names></name><name><surname>Stringer</surname><given-names>KA</given-names></name><name><surname>Jagadish</surname><given-names>HV</given-names></name><name><surname>Burant</surname><given-names>C</given-names></name><name><surname>Athey</surname><given-names>B</given-names></name><name><surname>Omenn</surname><given-names>GS</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Metscape 2 bioinformatics tool for the analysis and visualization of metabolomics and gene expression data</article-title><source>Bioinformatics</source><volume>28</volume><fpage>373</fpage><lpage>380</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btr661</pub-id><pub-id pub-id-type="pmid">22135418</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Lombard</surname><given-names>DB</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mitochondrial sirtuins and their relationships with metabolic disease and cancer</article-title><source>Antioxidants &amp; Redox Signaling</source><volume>22</volume><fpage>1060</fpage><lpage>1077</lpage><pub-id pub-id-type="doi">10.1089/ars.2014.6213</pub-id><pub-id pub-id-type="pmid">25545135</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lesner</surname><given-names>NP</given-names></name><name><surname>Gokhale</surname><given-names>AS</given-names></name><name><surname>Kota</surname><given-names>K</given-names></name><name><surname>DeBerardinis</surname><given-names>RJ</given-names></name><name><surname>Mishra</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>α-ketobutyrate links alterations in cystine metabolism to glucose oxidation in mtDNA mutant cells</article-title><source>Metabolic Engineering</source><volume>60</volume><fpage>157</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1016/j.ymben.2020.03.010</pub-id><pub-id pub-id-type="pmid">32330654</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Fu</surname><given-names>T</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Zhou</surname><given-names>D</given-names></name><name><surname>Xiao</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Kong</surname><given-names>Y</given-names></name><name><surname>Xie</surname><given-names>H</given-names></name><name><surname>Yi</surname><given-names>F</given-names></name><name><surname>Lai</surname><given-names>L</given-names></name><name><surname>Vega</surname><given-names>RB</given-names></name><name><surname>Kelly</surname><given-names>DP</given-names></name><name><surname>Smith</surname><given-names>SR</given-names></name><name><surname>Gan</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Exercise Inducible Lactate Dehydrogenase B Regulates Mitochondrial Function in Skeletal Muscle</article-title><source>The Journal of Biological Chemistry</source><volume>291</volume><fpage>25306</fpage><lpage>25318</lpage><pub-id pub-id-type="doi">10.1074/jbc.M116.749424</pub-id><pub-id pub-id-type="pmid">27738103</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>J-Z</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Ding</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Zhou</surname><given-names>S</given-names></name><name><surname>Lu</surname><given-names>X-C</given-names></name><name><surname>Yang</surname><given-names>H-B</given-names></name><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>Y-P</given-names></name><name><surname>Hu</surname><given-names>W</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>C</given-names></name><name><surname>Lei</surname><given-names>Q-Y</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Nuclear lactate dehydrogenase A senses ROS to produce α-hydroxybutyrate for HPV-induced cervical tumor growth</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>4429</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-06841-7</pub-id><pub-id pub-id-type="pmid">30356100</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mann</surname><given-names>G</given-names></name><name><surname>Mora</surname><given-names>S</given-names></name><name><surname>Madu</surname><given-names>G</given-names></name><name><surname>Adegoke</surname><given-names>OAJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Branched-chain Amino Acids: Catabolism in Skeletal Muscle and Implications for Muscle and Whole-body Metabolism</article-title><source>Frontiers in Physiology</source><volume>12</volume><elocation-id>702826</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2021.702826</pub-id><pub-id pub-id-type="pmid">34354601</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McBrayer</surname><given-names>SK</given-names></name><name><surname>Mayers</surname><given-names>JR</given-names></name><name><surname>DiNatale</surname><given-names>GJ</given-names></name><name><surname>Shi</surname><given-names>DD</given-names></name><name><surname>Khanal</surname><given-names>J</given-names></name><name><surname>Chakraborty</surname><given-names>AA</given-names></name><name><surname>Sarosiek</surname><given-names>KA</given-names></name><name><surname>Briggs</surname><given-names>KJ</given-names></name><name><surname>Robbins</surname><given-names>AK</given-names></name><name><surname>Sewastianik</surname><given-names>T</given-names></name><name><surname>Shareef</surname><given-names>SJ</given-names></name><name><surname>Olenchock</surname><given-names>BA</given-names></name><name><surname>Parker</surname><given-names>SJ</given-names></name><name><surname>Tateishi</surname><given-names>K</given-names></name><name><surname>Spinelli</surname><given-names>JB</given-names></name><name><surname>Islam</surname><given-names>M</given-names></name><name><surname>Haigis</surname><given-names>MC</given-names></name><name><surname>Looper</surname><given-names>RE</given-names></name><name><surname>Ligon</surname><given-names>KL</given-names></name><name><surname>Bernstein</surname><given-names>BE</given-names></name><name><surname>Carrasco</surname><given-names>RD</given-names></name><name><surname>Cahill</surname><given-names>DP</given-names></name><name><surname>Asara</surname><given-names>JM</given-names></name><name><surname>Metallo</surname><given-names>CM</given-names></name><name><surname>Yennawar</surname><given-names>NH</given-names></name><name><surname>Vander Heiden</surname><given-names>MG</given-names></name><name><surname>Kaelin</surname><given-names>WG</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Transaminase inhibition by 2-hydroxyglutarate impairs glutamate biosynthesis and redox homeostasis in glioma</article-title><source>Cell</source><volume>175</volume><fpage>101</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.08.038</pub-id><pub-id pub-id-type="pmid">30220459</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Min</surname><given-names>Z</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The Roles of Mitochondrial SIRT4 in Cellular Metabolism</article-title><source>Frontiers in Endocrinology</source><volume>9</volume><elocation-id>783</elocation-id><pub-id pub-id-type="doi">10.3389/fendo.2018.00783</pub-id><pub-id pub-id-type="pmid">30666234</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Minogue</surname><given-names>E</given-names></name><name><surname>Cunha</surname><given-names>PP</given-names></name><name><surname>Quaranta</surname><given-names>A</given-names></name><name><surname>Zurita</surname><given-names>J</given-names></name><name><surname>Teli</surname><given-names>SS</given-names></name><name><surname>Wadsworth</surname><given-names>BJ</given-names></name><name><surname>Hughes</surname><given-names>R</given-names></name><name><surname>Grice</surname><given-names>GL</given-names></name><name><surname>Velica</surname><given-names>P</given-names></name><name><surname>Bargiela</surname><given-names>D</given-names></name><name><surname>Barbieri</surname><given-names>L</given-names></name><name><surname>Wheelock</surname><given-names>CE</given-names></name><name><surname>Nathan</surname><given-names>JA</given-names></name><name><surname>Koivunen</surname><given-names>P</given-names></name><name><surname>Foskolou</surname><given-names>IP</given-names></name><name><surname>Johnson</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Glutarate Regulates T Cell Function and Metabolism</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2022.10.20.513065</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morville</surname><given-names>T</given-names></name><name><surname>Sahl</surname><given-names>RE</given-names></name><name><surname>Moritz</surname><given-names>T</given-names></name><name><surname>Helge</surname><given-names>JW</given-names></name><name><surname>Clemmensen</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Plasma Metabolome Profiling of Resistance Exercise and Endurance Exercise in Humans</article-title><source>Cell Reports</source><volume>33</volume><elocation-id>108554</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.108554</pub-id><pub-id pub-id-type="pmid">33378671</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neinast</surname><given-names>MD</given-names></name><name><surname>Jang</surname><given-names>C</given-names></name><name><surname>Hui</surname><given-names>S</given-names></name><name><surname>Murashige</surname><given-names>DS</given-names></name><name><surname>Chu</surname><given-names>Q</given-names></name><name><surname>Morscher</surname><given-names>RJ</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Zhan</surname><given-names>L</given-names></name><name><surname>White</surname><given-names>E</given-names></name><name><surname>Anthony</surname><given-names>TG</given-names></name><name><surname>Rabinowitz</surname><given-names>JD</given-names></name><name><surname>Arany</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Quantitative Analysis of the Whole-Body Metabolic Fate of Branched-Chain Amino Acids</article-title><source>Cell Metabolism</source><volume>29</volume><fpage>417</fpage><lpage>429</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2018.10.013</pub-id><pub-id pub-id-type="pmid">30449684</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paxton</surname><given-names>R</given-names></name><name><surname>Harris</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="1984">1984</year><article-title>Regulation of branched-chain alpha-ketoacid dehydrogenase kinase</article-title><source>Archives of Biochemistry and Biophysics</source><volume>231</volume><fpage>48</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/0003-9861(84)90361-8</pub-id><pub-id pub-id-type="pmid">6721501</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paxton</surname><given-names>R</given-names></name><name><surname>Scislowski</surname><given-names>PWD</given-names></name><name><surname>Davis</surname><given-names>EJ</given-names></name><name><surname>Harris</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>Role of branched-chain 2-oxo acid dehydrogenase and pyruvate dehydrogenase in 2-oxobutyrate metabolism</article-title><source>The Biochemical Journal</source><volume>234</volume><fpage>295</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1042/bj2340295</pub-id><pub-id pub-id-type="pmid">3718468</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pedregosa</surname><given-names>F</given-names></name><name><surname>Varoquaux</surname><given-names>G</given-names></name><name><surname>Gramfort</surname><given-names>A</given-names></name><name><surname>Michel</surname><given-names>V</given-names></name><name><surname>Thirion</surname><given-names>B</given-names></name><name><surname>Grisel</surname><given-names>O</given-names></name><name><surname>Blondel</surname><given-names>M</given-names></name><name><surname>Prettenhofer</surname><given-names>P</given-names></name><name><surname>Weiss</surname><given-names>R</given-names></name><name><surname>Dubourg</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Scikit-learn: Machine Learning in {P}ython</article-title><source>Journal of Machine Learning Research</source><volume>12</volume><fpage>2825</fpage><lpage>2830</lpage></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettit</surname><given-names>FH</given-names></name><name><surname>Yeaman</surname><given-names>SJ</given-names></name><name><surname>Reed</surname><given-names>LJ</given-names></name></person-group><year iso-8601-date="1978">1978</year><article-title>Purification and characterization of branched chain a-keto acid dehydrogenase complex of bovine kidney (multienzyme complex/subunit composition/structural organization)</article-title><source>PNAS</source><volume>75</volume><fpage>4881</fpage><lpage>4885</lpage></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname><given-names>A</given-names></name><name><surname>Bozi</surname><given-names>LHM</given-names></name><name><surname>Yaghi</surname><given-names>OK</given-names></name><name><surname>Mills</surname><given-names>EL</given-names></name><name><surname>Xiao</surname><given-names>H</given-names></name><name><surname>Nicholson</surname><given-names>HE</given-names></name><name><surname>Paschini</surname><given-names>M</given-names></name><name><surname>Paulo</surname><given-names>JA</given-names></name><name><surname>Garrity</surname><given-names>R</given-names></name><name><surname>Laznik-Bogoslavski</surname><given-names>D</given-names></name><name><surname>Ferreira</surname><given-names>JCB</given-names></name><name><surname>Carl</surname><given-names>CS</given-names></name><name><surname>Sjøberg</surname><given-names>KA</given-names></name><name><surname>Wojtaszewski</surname><given-names>JFP</given-names></name><name><surname>Jeppesen</surname><given-names>JF</given-names></name><name><surname>Kiens</surname><given-names>B</given-names></name><name><surname>Gygi</surname><given-names>SP</given-names></name><name><surname>Richter</surname><given-names>EA</given-names></name><name><surname>Mathis</surname><given-names>D</given-names></name><name><surname>Chouchani</surname><given-names>ET</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>pH-Gated Succinate Secretion Regulates Muscle Remodeling in Response to Exercise</article-title><source>Cell</source><volume>183</volume><fpage>62</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.08.039</pub-id><pub-id pub-id-type="pmid">32946811</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rundqvist</surname><given-names>H</given-names></name><name><surname>Veliça</surname><given-names>P</given-names></name><name><surname>Barbieri</surname><given-names>L</given-names></name><name><surname>Gameiro</surname><given-names>PA</given-names></name><name><surname>Bargiela</surname><given-names>D</given-names></name><name><surname>Gojkovic</surname><given-names>M</given-names></name><name><surname>Mijwel</surname><given-names>S</given-names></name><name><surname>Reitzner</surname><given-names>SM</given-names></name><name><surname>Wulliman</surname><given-names>D</given-names></name><name><surname>Ahlstedt</surname><given-names>E</given-names></name><name><surname>Ule</surname><given-names>J</given-names></name><name><surname>Östman</surname><given-names>A</given-names></name><name><surname>Johnson</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cytotoxic T-cells mediate exercise-induced reductions in tumor growth</article-title><source>eLife</source><volume>9</volume><elocation-id>e59996</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.59996</pub-id><pub-id pub-id-type="pmid">33095157</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryu</surname><given-names>KW</given-names></name><name><surname>Nandu</surname><given-names>T</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Challa</surname><given-names>S</given-names></name><name><surname>DeBerardinis</surname><given-names>RJ</given-names></name><name><surname>Kraus</surname><given-names>WL</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Metabolic regulation of transcription through compartmentalized NAD<sup>+</sup> biosynthesis</article-title><source>Science</source><volume>360</volume><elocation-id>eaan5780</elocation-id><pub-id pub-id-type="doi">10.1126/science.aan5780</pub-id><pub-id pub-id-type="pmid">29748257</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>S</given-names></name><name><surname>Dyar</surname><given-names>KA</given-names></name><name><surname>Treebak</surname><given-names>JT</given-names></name><name><surname>Jepsen</surname><given-names>SL</given-names></name><name><surname>Ehrlich</surname><given-names>AM</given-names></name><name><surname>Ashcroft</surname><given-names>SP</given-names></name><name><surname>Trost</surname><given-names>K</given-names></name><name><surname>Kunzke</surname><given-names>T</given-names></name><name><surname>Prade</surname><given-names>VM</given-names></name><name><surname>Small</surname><given-names>L</given-names></name><name><surname>Basse</surname><given-names>AL</given-names></name><name><surname>Schönke</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Samad</surname><given-names>M</given-names></name><name><surname>Baldi</surname><given-names>P</given-names></name><name><surname>Barrès</surname><given-names>R</given-names></name><name><surname>Walch</surname><given-names>A</given-names></name><name><surname>Moritz</surname><given-names>T</given-names></name><name><surname>Holst</surname><given-names>JJ</given-names></name><name><surname>Lutter</surname><given-names>D</given-names></name><name><surname>Zierath</surname><given-names>JR</given-names></name><name><surname>Sassone-Corsi</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Atlas of exercise metabolism reveals time-dependent signatures of metabolic homeostasis</article-title><source>Cell Metabolism</source><volume>34</volume><fpage>329</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2021.12.016</pub-id><pub-id pub-id-type="pmid">35030324</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Seabold</surname><given-names>S</given-names></name><name><surname>Perktold</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Statsmodels: Econometric and Statistical Modeling with Python</article-title><conf-name>Python in Science Conference</conf-name><conf-loc>Austin, Texas</conf-loc><pub-id pub-id-type="doi">10.25080/Majora-92bf1922-011</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>R</given-names></name><name><surname>Reinstadler</surname><given-names>B</given-names></name><name><surname>Engelstad</surname><given-names>K</given-names></name><name><surname>Skinner</surname><given-names>OS</given-names></name><name><surname>Stackowitz</surname><given-names>E</given-names></name><name><surname>Haller</surname><given-names>RG</given-names></name><name><surname>Clish</surname><given-names>CB</given-names></name><name><surname>Pierce</surname><given-names>K</given-names></name><name><surname>Walker</surname><given-names>MA</given-names></name><name><surname>Fryer</surname><given-names>R</given-names></name><name><surname>Oglesbee</surname><given-names>D</given-names></name><name><surname>Mao</surname><given-names>X</given-names></name><name><surname>Shungu</surname><given-names>DC</given-names></name><name><surname>Khatri</surname><given-names>A</given-names></name><name><surname>Hirano</surname><given-names>M</given-names></name><name><surname>De Vivo</surname><given-names>DC</given-names></name><name><surname>Mootha</surname><given-names>VK</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Circulating markers of NADH-reductive stress correlate with mitochondrial disease severity</article-title><source>The Journal of Clinical Investigation</source><volume>131</volume><elocation-id>e136055</elocation-id><pub-id pub-id-type="doi">10.1172/JCI136055</pub-id><pub-id pub-id-type="pmid">33463549</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sim</surname><given-names>J</given-names></name><name><surname>Cowburn</surname><given-names>AS</given-names></name><name><surname>Palazon</surname><given-names>A</given-names></name><name><surname>Madhu</surname><given-names>B</given-names></name><name><surname>Tyrakis</surname><given-names>PA</given-names></name><name><surname>Macías</surname><given-names>D</given-names></name><name><surname>Bargiela</surname><given-names>DM</given-names></name><name><surname>Pietsch</surname><given-names>S</given-names></name><name><surname>Gralla</surname><given-names>M</given-names></name><name><surname>Evans</surname><given-names>CE</given-names></name><name><surname>Kittipassorn</surname><given-names>T</given-names></name><name><surname>Chey</surname><given-names>YCJ</given-names></name><name><surname>Branco</surname><given-names>CM</given-names></name><name><surname>Rundqvist</surname><given-names>H</given-names></name><name><surname>Peet</surname><given-names>DJ</given-names></name><name><surname>Johnson</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The factor inhibiting HIF asparaginyl hydroxylase regulates oxidative metabolism and accelerates metabolic adaptation to hypoxia</article-title><source>Cell Metabolism</source><volume>27</volume><fpage>898</fpage><lpage>913</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2018.02.020</pub-id><pub-id pub-id-type="pmid">29617647</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steele</surname><given-names>RD</given-names></name><name><surname>Weber</surname><given-names>H</given-names></name><name><surname>Patterson</surname><given-names>JI</given-names></name></person-group><year iso-8601-date="1984">1984</year><article-title>Characterization of alpha-ketobutyrate metabolism in rat tissues: effects of dietary protein and fasting</article-title><source>The Journal of Nutrition</source><volume>114</volume><fpage>701</fpage><lpage>710</lpage><pub-id pub-id-type="doi">10.1093/jn/114.4.701</pub-id><pub-id pub-id-type="pmid">6716171</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>LB</given-names></name><name><surname>Gui</surname><given-names>DY</given-names></name><name><surname>Hosios</surname><given-names>AM</given-names></name><name><surname>Bush</surname><given-names>LN</given-names></name><name><surname>Freinkman</surname><given-names>E</given-names></name><name><surname>Vander Heiden</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells</article-title><source>Cell</source><volume>162</volume><fpage>552</fpage><lpage>563</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.07.017</pub-id><pub-id pub-id-type="pmid">26232225</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Talaiezadeh</surname><given-names>A</given-names></name><name><surname>Shahriari</surname><given-names>A</given-names></name><name><surname>Tabandeh</surname><given-names>MR</given-names></name><name><surname>Fathizadeh</surname><given-names>P</given-names></name><name><surname>Mansouri</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Kinetic characterization of lactate dehydrogenase in normal and malignant human breast tissues</article-title><source>Cancer Cell International</source><volume>15</volume><elocation-id>19</elocation-id><pub-id pub-id-type="doi">10.1186/s12935-015-0171-7</pub-id><pub-id pub-id-type="pmid">25705126</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson Legault</surname><given-names>J</given-names></name><name><surname>Strittmatter</surname><given-names>L</given-names></name><name><surname>Tardif</surname><given-names>J</given-names></name><name><surname>Sharma</surname><given-names>R</given-names></name><name><surname>Tremblay-Vaillancourt</surname><given-names>V</given-names></name><name><surname>Aubut</surname><given-names>C</given-names></name><name><surname>Boucher</surname><given-names>G</given-names></name><name><surname>Clish</surname><given-names>CB</given-names></name><name><surname>Cyr</surname><given-names>D</given-names></name><name><surname>Daneault</surname><given-names>C</given-names></name><name><surname>Waters</surname><given-names>PJ</given-names></name><name><surname>Vachon</surname><given-names>L</given-names></name><name><surname>Morin</surname><given-names>C</given-names></name><name><surname>Laprise</surname><given-names>C</given-names></name><name><surname>Rioux</surname><given-names>JD</given-names></name><name><surname>Mootha</surname><given-names>VK</given-names></name><name><surname>Des Rosiers</surname><given-names>C</given-names></name><collab>LSFC Consortium</collab></person-group><year iso-8601-date="2015">2015</year><article-title>A metabolic signature of mitochondrial dysfunction revealed through a monogenic form of leigh syndrome</article-title><source>Cell Reports</source><volume>13</volume><fpage>981</fpage><lpage>989</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2015.09.054</pub-id><pub-id pub-id-type="pmid">26565911</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyrakis</surname><given-names>PA</given-names></name><name><surname>Palazon</surname><given-names>A</given-names></name><name><surname>Macias</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>KL</given-names></name><name><surname>Phan</surname><given-names>AT</given-names></name><name><surname>Veliça</surname><given-names>P</given-names></name><name><surname>You</surname><given-names>J</given-names></name><name><surname>Chia</surname><given-names>GS</given-names></name><name><surname>Sim</surname><given-names>J</given-names></name><name><surname>Doedens</surname><given-names>A</given-names></name><name><surname>Abelanet</surname><given-names>A</given-names></name><name><surname>Evans</surname><given-names>CE</given-names></name><name><surname>Griffiths</surname><given-names>JR</given-names></name><name><surname>Poellinger</surname><given-names>L</given-names></name><name><surname>Goldrath</surname><given-names>AW</given-names></name><name><surname>Johnson</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fate</article-title><source>Nature</source><volume>540</volume><fpage>236</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1038/nature20165</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Morze</surname><given-names>C</given-names></name><name><surname>Bok</surname><given-names>RA</given-names></name><name><surname>Ohliger</surname><given-names>MA</given-names></name><name><surname>Zhu</surname><given-names>Z</given-names></name><name><surname>Vigneron</surname><given-names>DB</given-names></name><name><surname>Kurhanewicz</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Hyperpolarized [(13)C]ketobutyrate, a molecular analog of pyruvate with modified specificity for LDH isoforms</article-title><source>Magnetic Resonance in Medicine</source><volume>75</volume><fpage>1894</fpage><lpage>1900</lpage><pub-id pub-id-type="doi">10.1002/mrm.25716</pub-id><pub-id pub-id-type="pmid">26059096</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Wadsworth</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>JohnsonLab_Wadsworth-et-al_2hb-metabolomics</data-title><version designator="swh:1:rev:55c508d398f8672c8dcebd34ceb42dab36729786">swh:1:rev:55c508d398f8672c8dcebd34ceb42dab36729786</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:cb3200c91847fecbf683e5b2220beb03556ca77b;origin=https://github.com/bjwadswo/JohnsonLab_Wadsworth-et-al_2HB-Metabolomics;visit=swh:1:snp:ab239f95bf87d7563f55a92d560512add7ee8dfa;anchor=swh:1:rev:55c508d398f8672c8dcebd34ceb42dab36729786">https://archive.softwareheritage.org/swh:1:dir:cb3200c91847fecbf683e5b2220beb03556ca77b;origin=https://github.com/bjwadswo/JohnsonLab_Wadsworth-et-al_2HB-Metabolomics;visit=swh:1:snp:ab239f95bf87d7563f55a92d560512add7ee8dfa;anchor=swh:1:rev:55c508d398f8672c8dcebd34ceb42dab36729786</ext-link></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waskom</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>seaborn: statistical data visualization</article-title><source>Journal of Open Source Software</source><volume>6</volume><elocation-id>3021</elocation-id><pub-id pub-id-type="doi">10.21105/joss.03021</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>PJ</given-names></name><name><surname>McGarrah</surname><given-names>RW</given-names></name><name><surname>Grimsrud</surname><given-names>PA</given-names></name><name><surname>Tso</surname><given-names>SC</given-names></name><name><surname>Yang</surname><given-names>WH</given-names></name><name><surname>Haldeman</surname><given-names>JM</given-names></name><name><surname>Grenier-Larouche</surname><given-names>T</given-names></name><name><surname>An</surname><given-names>J</given-names></name><name><surname>Lapworth</surname><given-names>AL</given-names></name><name><surname>Astapova</surname><given-names>I</given-names></name><name><surname>Hannou</surname><given-names>SA</given-names></name><name><surname>George</surname><given-names>T</given-names></name><name><surname>Arlotto</surname><given-names>M</given-names></name><name><surname>Olson</surname><given-names>LB</given-names></name><name><surname>Lai</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>GF</given-names></name><name><surname>Ilkayeva</surname><given-names>O</given-names></name><name><surname>Herman</surname><given-names>MA</given-names></name><name><surname>Wynn</surname><given-names>RM</given-names></name><name><surname>Chuang</surname><given-names>DT</given-names></name><name><surname>Newgard</surname><given-names>CB</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The BCKDH kinase and phosphatase integrate BCAA and Lipid metabolism via regulation of atp-citrate lyase</article-title><source>Cell Metabolism</source><volume>27</volume><fpage>1281</fpage><lpage>1293</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2018.04.015</pub-id><pub-id pub-id-type="pmid">29779826</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>C</given-names></name><name><surname>Ma</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Duan</surname><given-names>C</given-names></name><name><surname>Yuan</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Gao</surname><given-names>P</given-names></name><name><surname>Shu</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Jiang</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Hypoxanthine induces muscular ATP depletion and fatigue via UCP2</article-title><source>Frontiers in Physiology</source><volume>12</volume><elocation-id>647743</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2021.647743</pub-id><pub-id pub-id-type="pmid">33746782</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaganjor</surname><given-names>E</given-names></name><name><surname>Yoon</surname><given-names>H</given-names></name><name><surname>Spinelli</surname><given-names>JB</given-names></name><name><surname>Nunn</surname><given-names>ER</given-names></name><name><surname>Laurent</surname><given-names>G</given-names></name><name><surname>Keskinidis</surname><given-names>P</given-names></name><name><surname>Sivaloganathan</surname><given-names>S</given-names></name><name><surname>Joshi</surname><given-names>S</given-names></name><name><surname>Notarangelo</surname><given-names>G</given-names></name><name><surname>Mulei</surname><given-names>S</given-names></name><name><surname>Chvasta</surname><given-names>MT</given-names></name><name><surname>Tucker</surname><given-names>SA</given-names></name><name><surname>Kalafut</surname><given-names>K</given-names></name><name><surname>van de Ven</surname><given-names>RAH</given-names></name><name><surname>Clish</surname><given-names>CB</given-names></name><name><surname>Haigis</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>SIRT4 is an early regulator of branched-chain amino acid catabolism that promotes adipogenesis</article-title><source>Cell Reports</source><volume>36</volume><elocation-id>109345</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2021.109345</pub-id><pub-id pub-id-type="pmid">34260923</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92707.2.sa0</article-id><title-group><article-title>eLife assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Parker</surname><given-names>Benjamin L</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>University of Melbourne</institution><country>Australia</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Convincing</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group></front-stub><body><p>The work by Johnson and co-workers has identified an <bold>important</bold> role of 2-Hydroxybutyrate in skeletal muscle oxidative capacity in the early stages of exercise. Mechanistically, they show <bold>convincing</bold> data to support a role of 2-Hydroxybutyrate in the regulation of BCAA metabolism via SIRT4, ADP-Ribosylation, and CEBP. However, whether this is the sole mechanism and if these translate to longer exercise training regimes requires future experiments.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92707.2.sa1</article-id><title-group><article-title>Reviewer #1 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>The authors aimed to investigate if 2-hydroxybutyrate (2HB), a metabolite induced by exercise, influences physiological changes, particularly metabolic alterations post-exercise training. They treated young mice and cultured myoblasts with 2HB, conducted exercise tests, metabolomic profiling, gene expression analysis, and knockdown experiments to understand 2HB's mechanisms. Their findings indicate that 2HB enhances exercise tolerance, boosts branch chain amino acid (BCAA) enzyme gene expression in skeletal muscles, and increases oxidative capacity. They also highlight the role of SIRT4 in these effects. This study establishes 2HB, once considered a waste product, as a regulator of exercise-induced metabolic processes. The study's strength lies in its consistent results across in vitro, in vivo, and ex vivo analyses. The authors propose a mechanism in which 2HB inhibits BCAA breakdown, raises NAD+/NADH ratio, activates SIRT4, increases ADP ribosylation, and controls gene expression.</p><p>However, some questions remain unclear based on these findings:</p><p>This study focused on the effects of short-term exercise (1 or 5 bouts of treadmill running) and short-term 2HB treatment (1 or 4 days of treatment). Adaptations to exercise training typically occur progressively over an extended period. It's important to investigate the effects of long-term 2HB treatment and whether extended combined 2HB treatment and exercise training have independent, synergistic, or antagonistic effects.</p><p>Exercise training leads to significant mitochondrial changes, including increased mitochondrial biogenesis in skeletal muscle. It would be valuable to compare the impact of 2HB treatment on mitochondrial content and oxidative capacity in treated mice to that in exercised mice.</p><p>The authors demonstrate that 2-ketobutyrate (2KB) can serve as an oxidative fuel, suggesting a role for the intact BCAA catabolic pathway. However, it's puzzling that the knockout of BCKDHA, a subunit crucial for the second step of BCAA catabolism, did not result in changes in oxidative capacity in cultured myoblasts.</p><p>Nevertheless, this innovative model of metabolic signaling during exercise will serve as a valuable reference for informing future.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92707.2.sa2</article-id><title-group><article-title>Reviewer #2 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>The manuscript entitled &quot;A 2-HB-mediated feedback loop regulates muscular fatigue&quot; by the Johnson group reports interesting findings with implications for the health benefits of exercise. The authors use a combination of metabolic/biochemical in vivo and in vitro assays to delineate a metabolic route triggered by 2-HB (a relatively stable metabolite induced by exercise in humans and mice) that controls branched-chain amino transferase enzymes and mitochondrial oxidative capacity. Mechanistically, the author shows that 2-HB is a direct inhibitor of BCAT enzymes that in turn control levels of SIRT4 activity and ADp-ribosylation in the nucleus targeting C/EBP transcription factor, affecting BCAA oxidation genes (see Fig 4i in the paper). Overall, these are interesting and novel observations and findings with relevance to human exercise, with the potential implication of using these metabolites to mimic exercise benefits, or conditions or muscular fatigue that occurs in different human chronic diseases including rheumatic diseases or long COVID.</p><p>Weaknesses:</p><p>There are several experiments/comments that will strengthen the manuscript-</p><p>1- A final model in Figure 6 integrating the exercise/mechanistic findings, expanding on Fig 4i will clarify the findings.</p><p>2- In some of the graphs, statistics are missing (e.g Fig 6G).</p><p>3- The conclusions on SIRT4 dependency should be carefully written, as it is likely that this is only one potential mechanism, further validation with mouse models would be necessary.</p><p>4- One of the needed experiments to support the oxidative capacity effects that could be done in cultured cells, is the use of radiosotope metabolites including BCCAs to determine the ability to produce CO2. Alternatively or in combination metabolite flux using isotopes would be useful to strengthen the current results.</p></body></sub-article><sub-article article-type="author-comment" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92707.2.sa3</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wadsworth</surname><given-names>Brennan J</given-names></name><role specific-use="author">Author</role><aff><institution>Karolinska Institute</institution><addr-line><named-content content-type="city">Stockholm</named-content></addr-line><country>Sweden</country></aff></contrib><contrib contrib-type="author"><name><surname>Leiwe</surname><given-names>Marina</given-names></name><role specific-use="author">Author</role><aff><institution>Karolinska Institute</institution><addr-line><named-content content-type="city">Stockholm</named-content></addr-line><country>Sweden</country></aff></contrib><contrib contrib-type="author"><name><surname>Minogue</surname><given-names>Eleanor</given-names></name><role specific-use="author">Author</role><aff><institution>University of Cambridge</institution><addr-line><named-content content-type="city">Cambridge</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Cunha</surname><given-names>Pedro P</given-names></name><role specific-use="author">Author</role><aff><institution>University of Cambridge</institution><addr-line><named-content content-type="city">Cambridge</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Engman</surname><given-names>Viktor</given-names></name><role specific-use="author">Author</role><aff><institution>Karolinska Institute</institution><addr-line><named-content content-type="city">Stockholm</named-content></addr-line><country>Sweden</country></aff></contrib><contrib contrib-type="author"><name><surname>Brombach</surname><given-names>Carolin</given-names></name><role specific-use="author">Author</role><aff><institution>Karolinska Institute</institution><addr-line><named-content content-type="city">Stockholm</named-content></addr-line><country>Sweden</country></aff></contrib><contrib contrib-type="author"><name><surname>Asvestis</surname><given-names>Christos</given-names></name><role specific-use="author">Author</role><aff><institution>Karolinska Institute</institution><addr-line><named-content content-type="city">Stockholm</named-content></addr-line><country>Sweden</country></aff></contrib><contrib contrib-type="author"><name><surname>Sah-Teli</surname><given-names>Shiv K</given-names></name><role specific-use="author">Author</role><aff><institution>University of Cambridge</institution><addr-line><named-content content-type="city">Cambridge</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Marklund</surname><given-names>Emilia</given-names></name><role specific-use="author">Author</role><aff><institution>Karolinska Institute</institution><addr-line><named-content content-type="city">Stockholm</named-content></addr-line><country>Sweden</country></aff></contrib><contrib contrib-type="author"><name><surname>Koivunen</surname><given-names>Peppi</given-names></name><role specific-use="author">Author</role><aff><institution>University of Oulu</institution><addr-line><named-content content-type="city">Oulu</named-content></addr-line><country>Finland</country></aff></contrib><contrib contrib-type="author"><name><surname>Ruas</surname><given-names>Jorge Lira</given-names></name><role specific-use="author">Author</role><aff><institution>Karolinska Institute</institution><addr-line><named-content content-type="city">Stockholm</named-content></addr-line><country>Sweden</country></aff></contrib><contrib contrib-type="author"><name><surname>Rundqvist</surname><given-names>Helene</given-names></name><role specific-use="author">Author</role><aff><institution>Karolinska Institutet</institution><addr-line><named-content content-type="city">Stockholm</named-content></addr-line><country>Sweden</country></aff></contrib><contrib contrib-type="author"><name><surname>Lanner</surname><given-names>Johanna</given-names></name><role specific-use="author">Author</role><aff><institution>Karolinska Institutet</institution><addr-line><named-content content-type="city">Stockholm</named-content></addr-line><country>Sweden</country></aff></contrib><contrib contrib-type="author"><name><surname>Johnson</surname><given-names>Randall S</given-names></name><role specific-use="author">Author</role><aff><institution>Karolinska Institute</institution><addr-line><named-content content-type="city">Cambridge</named-content></addr-line><country>United Kingdom</country></aff></contrib></contrib-group></front-stub><body><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Public Review):</bold></p><p>The authors aimed to investigate if 2-hydroxybutyrate (2HB), a metabolite induced by exercise, influences physiological changes, particularly metabolic alterations post-exercise training. They treated young mice and cultured myoblasts with 2HB, conducted exercise tests, metabolomic profiling, gene expression analysis, and knockdown experiments to understand 2HB's mechanisms. Their findings indicate that 2HB enhances exercise tolerance, boosts branch chain amino acid (BCAA) enzyme gene expression in skeletal muscles, and increases oxidative capacity. They also highlight the role of SIRT4 in these effects. This study establishes 2HB, once considered a waste product, as a regulator of exercise-induced metabolic processes. The study's strength lies in its consistent results across in vitro, in vivo, and ex vivo analyses.</p><p>The authors propose a mechanism in which 2HB inhibits BCAA breakdown, raises NAD+/NADH ratio, activates SIRT4, increases ADP ribosylation, and controls gene expression.</p><p>However, some questions remain unclear based on these findings:</p><p>This study focused on the effects of short-term exercise (1 or 5 bouts of treadmill running) and short-term 2HB treatment (1 or 4 days of treatment). Adaptations to exercise training typically occur progressively over an extended period. It's important to investigate the effects of long-term 2HB treatment and whether extended combined 2HB treatment and exercise training have independent, synergistic, or antagonistic effects.</p></disp-quote><p>We agree with the reviewer that investigation of longer-term 2HB treatment may potentially yield interesting findings with more implications to exercise physiology. To investigate the effects of 2HB treatment against or in combination with a progressive exercise training protocol would require an experiment duration between 4 to 12 weeks, based on previous studies (Systematic Review by Massett et al., Frontiers in Physiology, 2021, 10.3389/fphys.2021.782695). However, our experience with these types of experiments is that such a pursuit would require a breadth of work beyond the scope of this current study. For instance, if there were evidence of weakened effect of 2HB over time, one may be compelled to investigate other organs such as the liver to find signs of metabolic adaptation to the exogenous metabolite. If there were additive or synergistic effects on exercise performance, one may be compelled to investigate changes to the cardiovascular system in addition to the skeletal muscle. Additional questions would be raised around the skeletal muscle as well, including assessment of structural and fibre-type changes. Further, these additional mechanisms would need to be characterized in a time course fashion. Rather, we view the scope of the current study to be the acute response to 2HB as an initial report on mechanistic effects of 2HB.</p><disp-quote content-type="editor-comment"><p>Exercise training leads to significant mitochondrial changes, including increased mitochondrial biogenesis in skeletal muscle. It would be valuable to compare the impact of 2HB treatment on mitochondrial content and oxidative capacity in treated mice to that in exercised mice.</p></disp-quote><p>We agree with the author that it is of interest to investigate how 2HB may affect mitochondrial biogenesis. However, our preliminary findings were that 2HB-treated MEFs, C2C12s, and mouse soleus muscles showed no change in PGC1α gene expression after four days of treatment (data not shown). As a follow-up assessment of mitochondrial protein expression, although not specific to mtDNA derived genes, we quantified the expression of the respiratory chain proteins in cells and soleus muscle and found no effect of 2HB treatment (SFig. 5,6). At this stage we conclude that there is not evidence of 2HB modifying mitochondrial biogenesis in this time frame and that further investigation would be best suited to a follow-up study such as one interested in long-term exercise training.</p><disp-quote content-type="editor-comment"><p>The authors demonstrate that 2-ketobutyrate (2KB) can serve as an oxidative fuel, suggesting a role for the intact BCAA catabolic pathway. However, it's puzzling that the knockout of BCKDHA, a subunit crucial for the second step of BCAA catabolism, did not result in changes in oxidative capacity in cultured myoblasts.</p></disp-quote><p>While we report the BCKDH complex to be dispensable for 2KB oxidation it is important to note that previous studies have reported the following: (1) that 2KB is a viable substrate for BCKDH, (2) that 2KB is a viable substrate for pyruvate dehydrogenase, and (3) that pyruvate dehydrogenase is also dispensable for 2KB oxidation (see Steele et al., J Nutr., 114: 701-710, and Paxton et al. Biochem J., 234:295-303). Collectively, these data have led previous studies to conclude that BCKDH and pyruvate dehydrogenase are redundant for the first step of 2KB oxidation, with a preference for BCKDH. The flux through either may depend upon the metabolic environment. The aim for figure 3C was to determine whether the BCAA degradation pathway was required for 2KB oxidation. We conclude that this pathway is required, first at the step of PCC.</p><p>While these past studies were mentioned in paragraph 2 of the discussion, in light of thereviewer’s comment we have expanded this paragraph. We have added language to explain that future research interested in the presented 2HB mechanism should carefully consider BCKDH and PDH expression in the cell or tissue of interest, as the metabolism of 2KB is quite central to the presented mechanism.</p><disp-quote content-type="editor-comment"><p>Nevertheless, this innovative model of metabolic signaling during exercise will serve as a valuable reference for informing future.</p><p><bold>Reviewer #2 (Public Review):</bold></p><p>Summary:</p><p>The manuscript entitled &quot;A 2-HB-mediated feedback loop regulates muscular fatigue&quot; by the Johnson group reports interesting findings with implications for the health benefits of exercise. The authors use a combination of metabolic/biochemical in vivo and in vitro assays to delineate a metabolic route triggered by 2-HB (a relatively stable metabolite induced by exercise in humans and mice) that controls branched-chain amino transferase enzymes and mitochondrial oxidative capacity. Mechanistically, the author shows that 2-HB is a direct inhibitor of BCAT enzymes that in turn control levels of SIRT4 activity and ADp-ribosylation in the nucleus targeting C/EBP transcription factor, affecting BCAA oxidation genes (see Fig 4i in the paper). Overall, these are interesting and novel observations and findings with relevance to human exercise, with the potential implication of using these metabolites to mimic exercise benefits, or conditions or muscular fatigue that occurs in different human chronic diseases including rheumatic diseases or long COVID.</p><p>Weaknesses:</p><p>There are several experiments/comments that will strengthen the manuscript-</p><p>(1) A final model in Figure 6 integrating the exercise/mechanistic findings, expanding on Fig 4i will clarify the findings.</p></disp-quote><p>We appreciate the reviewer’s suggestion to incorporate the exercise findings into a summary figure. However, upon internal review we find that such a figure is too similar to Fig 4i to warrant a new diagram.</p><disp-quote content-type="editor-comment"><p>(2) In some of the graphs, statistics are missing (e.g Fig 6G).</p></disp-quote><p>Some figures are included primarily for the reader to visualize the data while statistical comparison is conducted in a separate figure, for example Fig 2D-G. However, we have revised the figure legends to ensure that statistical comparisons are described for all appropriate figures, including Fig 6G identified by the reviewer.</p><disp-quote content-type="editor-comment"><p>(3) The conclusions on SIRT4 dependency should be carefully written, as it is likely that this is only one potential mechanism, further validation with mouse models would be necessary.</p></disp-quote><p>We appreciate the reviewers feedback and take the point well that a NAD-dependent mechanism will likely stimulate other sirtuins, which are often in fact expressed at greater levels than SIRT4. To reflect this comment in the manuscript we have altered paragraph 5 of the discussion to now focus on sirtuins. We briefly discuss SIRT4 and highlight the need for future consideration of other sirtuins, perhaps particularly mitochondrial sirtuins.</p><disp-quote content-type="editor-comment"><p>(4) One of the needed experiments to support the oxidative capacity effects that could be done in cultured cells, is the use of radiosotope metabolites including BCCAs to determine the ability to produce CO2. Alternatively or in combination metabolite flux using isotopes would be useful to strengthen the current results.</p></disp-quote><p>We appreciate the suggestion from the reviewer and we will look to conduct such an experiment in our follow-up work.</p><p>We sincerely thank the reviewers for their input on this study as their suggestions have led to an improved manuscript for the version of record. The reviewer comments are well taken and we are glad that they will be present alongside the final manuscript to provide an important perspective on the work.</p></body></sub-article></article>